| 1 |
Han YH, Zhang W, Wang YT, Xiong ZJ, Du Q, Xie Y, Lu H. Performance evaluation of a novel 14C-urea breath test (solid scintillation) for the diagnosis of helicobacter pylori infection. Medicine (Baltimore) 2023;102:e33107. [PMID: 36862867 DOI: 10.1097/MD.0000000000033107] [Reference Citation Analysis]
|
| 2 |
Correia C, Almeida N, Leal C, Branquinho D, Fernandes A, Gravito-Soares E, Calhau C, Bastos I, Vasconcelos H, Figueiredo P. Single-capsule bismuth-based quadruple therapy as a rescue therapy for Helicobacter pylori eradication. Scand J Gastroenterol 2023;58:227-31. [PMID: 36189844 DOI: 10.1080/00365521.2022.2119097] [Reference Citation Analysis]
|
| 3 |
Baskaradoss JK, Behbehani E, Karched M. Effect of Miswak Chewing Sticks on Oral Helicobacter Pylori under both fasting and non-fasting conditions – A preliminary cross-over randomized clinical trial. Journal of Herbal Medicine 2023. [DOI: 10.1016/j.hermed.2023.100646] [Reference Citation Analysis]
|
| 4 |
Bonvegna S, Cilia R. Disease mechanisms as subtypes: Microbiome. Handb Clin Neurol 2023;193:107-31. [PMID: 36803806 DOI: 10.1016/B978-0-323-85555-6.00006-0] [Reference Citation Analysis]
|
| 5 |
Peng X, Chen H, Wan Y, Su P, Yu J, Liu J, Lu Y, Zhang M, Yao J, Zhi M. Combination of vonoprazan and amoxicillin as the first-line Helicobacter pylori eradication therapy: a multicenter, prospective, randomized, parallel-controlled study.. [DOI: 10.21203/rs.3.rs-2547217/v1] [Reference Citation Analysis]
|
| 6 |
Na G, He C, Zhang S, Tian S, Bao Y, Shan Y. Dietary Isothiocyanates: Novel Insights into the Potential for Cancer Prevention and Therapy. Int J Mol Sci 2023;24. [PMID: 36768284 DOI: 10.3390/ijms24031962] [Reference Citation Analysis]
|
| 7 |
Braendli T, Schindler V, Braun DL, Murray FR, Hente JM, Pohl D. Clarithromycin-based Helicobacter pylori eradication therapy is not associated with higher treatment failure compared with non-clarithromycin-based regimens in a tertiary referral hospital in Switzerland. Swiss Med Wkly 2023;153:40024. [PMID: 36652712 DOI: 10.57187/smw.2023.40024] [Reference Citation Analysis]
|
| 8 |
Kutikuppala LS, Nulukurthi T, Karnasula B, Kumar Chowdary R, Chintala J. An assessment of peptic ulcer perforation score: A predictor of mortality following peptic ulcer perforation from a rural tertiary care setting. Arch Med Health Sci 2023;0:0. [DOI: 10.4103/amhs.amhs_248_22] [Reference Citation Analysis]
|
| 9 |
Miftahussurur M, Waskito LA, Syam AF, Nusi IA, Wibawa IDN, Rezkitha YAA, Fauzia KA, Siregar GA, Akil F, Waleleng BJ, Saudale AMJ, Abubakar A, Maulahela H, Richardo M, Rahman A, Namara YS, Sudarmo E, Adi P, Maimunah U, Setiawan PB, Doohan D, Uchida T, Dewayani A, Rejeki PS, Sugihartono T, Yamaoka Y. Serum pepsinogen level as a biomarker for atrophy, reflux esophagitis, and gastric cancer screening in Indonesia. J Res Med Sci 2022;27:90. [PMID: 36685023 DOI: 10.4103/jrms.jrms_983_21] [Reference Citation Analysis]
|
| 10 |
Zhou M, Zeng Y, Xi Y, Luo S, Qi J, Zhao G, Sun Y, Guo Y, Cheng F. School-based Hygiene Intervention to Prevent HelicObacter Pylori infection among childrEn (SHIP HOPE): protocol for a cluster-randomised controlled trial. BMJ Open 2022;12:e064207. [PMID: 36600426 DOI: 10.1136/bmjopen-2022-064207] [Reference Citation Analysis]
|
| 11 |
Yunusa I, Love BL. Cost-Effectiveness of Vonoprazan- and Rifabutin-Based vs. Other Regimens as First-Line Treatment of Helicobacter Pylori Infection in the United States. Am J Gastroenterol 2022. [PMID: 36693030 DOI: 10.14309/ajg.0000000000002146] [Reference Citation Analysis]
|
| 12 |
Kato S, Gold BD, Kato A. Helicobacter pylori-Associated Iron Deficiency Anemia in Childhood and Adolescence-Pathogenesis and Clinical Management Strategy. J Clin Med 2022;11. [PMID: 36555966 DOI: 10.3390/jcm11247351] [Reference Citation Analysis]
|
| 13 |
Ma Z, Chu X, Yan X, Wang W. Association between Helicobacter pylori infection and non-alcoholic fatty liver disease for Asian and non-Asian population: A systematic review and meta-analysis. Front Public Health 2022;10:1062942. [PMID: 36568787 DOI: 10.3389/fpubh.2022.1062942] [Reference Citation Analysis]
|
| 14 |
Arjmandi D, Abdollahi A, Ardekani A, Razavian I, Razavian E, Sartip B, Mahjour S, Parsa H, Kyvanani NA, Marhoommirzabak E, Kountouras J, Rostami A. Helicobacter pylori infection and risk of multiple sclerosis: An updated meta-analysis. Helicobacter 2022;27:e12927. [PMID: 36046943 DOI: 10.1111/hel.12927] [Reference Citation Analysis]
|
| 15 |
Stayoussef M, Zidi S, Kanabekova P, Mouellhi L, Almawi WY, Yaacoubi-Loueslati B. Relation of CRP gene variants to altered risk of Helicobacter pylori - associated chronic gastritis: A case-control study in Tunisia. Mol Cell Probes 2022;66:101864. [PMID: 36162594 DOI: 10.1016/j.mcp.2022.101864] [Reference Citation Analysis]
|
| 16 |
Wu D, Li X, Li T, Xie W, Liu Y, Tan Q, Wu W, Sun Z, Chen T, Jiang H, Li J, Qin J, Zhao Y, Chen W. The Effect of Quadruple Therapy with Polaprezinc or Bismuth on Gut Microbiota after Helicobacter pylori Eradication: A Randomized Controlled Trial. J Clin Med 2022;11. [PMID: 36498624 DOI: 10.3390/jcm11237050] [Reference Citation Analysis]
|
| 17 |
Yu YY, Tong YL, Wu LY, Yu XY. Helicobacter pylori infection eradication for nonalcoholic fatty liver disease: a randomized controlled trial. Sci Rep 2022;12:19530. [PMID: 36376474 DOI: 10.1038/s41598-022-23746-0] [Reference Citation Analysis]
|
| 18 |
Pettersson AK, Santoni G, Yan J, Radkiewicz C, Xie S, Birgisson H, Ness-Jensen E, von Euler-Chelpin M, Kauppila JH, Lagergren J. Cohort profile: Nordic Helicobacter Pylori eradication project (NordHePEP). Scand J Gastroenterol 2022;:1-7. [PMID: 36369751 DOI: 10.1080/00365521.2022.2144435] [Reference Citation Analysis]
|
| 19 |
Bisht N, P. Garg A. Helicobacter pylori Gastric Infection: Pathogenesis and Clinical Management. Helicobacter pylori Infection - An Up to Date on the Pathogenic Mechanisms, Diagnosis and Clinical Management [Working Title] 2022. [DOI: 10.5772/intechopen.106783] [Reference Citation Analysis]
|
| 20 |
Wang D, Chen Y, Ding Y, Tu J. Inverse association between Helicobacter pylori infection and childhood asthma in a physical examination population: a cross-sectional study in Chongqing, China. BMC Pediatr 2022;22:615. [PMID: 36289457 DOI: 10.1186/s12887-022-03682-8] [Reference Citation Analysis]
|
| 21 |
Tseng Y, Liou J, Cheng W, Hsu J, Hsu T, Wu M, Wong C. Combating multidrug-resistant Helicobacter pylori with moenomycin A in combination with clarithromycin or metronidazole. Front Chem 2022;10:897578. [DOI: 10.3389/fchem.2022.897578] [Reference Citation Analysis]
|
| 22 |
Markandan K, Tiong YW, Sankaran R, Subramanian S, Markandan UD, Chaudhary V, Numan A, Khalid M, Walvekar R. Emergence of infectious diseases and role of advanced nanomaterials in point-of-care diagnostics: a review. Biotechnol Genet Eng Rev 2022;:1-89. [PMID: 36243900 DOI: 10.1080/02648725.2022.2127070] [Reference Citation Analysis]
|
| 23 |
Alsohaibani F, Peedikayil M, Alshahrani A, Somily A, Alsulaiman R, Azzam N, Almadi M. Practice guidelines for the management of Helicobacter pylori infection: The Saudi H. pylori Working Group recommendations. Saudi J Gastroenterol 2022. [PMID: 36204804 DOI: 10.4103/sjg.sjg_288_22] [Reference Citation Analysis]
|
| 24 |
Wang JW, Hsu PI, Lin MH, Kao J, Tsay FW, Wu IT, Shie CB, Wu DC. The efficacy of culture-guided versus empirical therapy with high-dose proton pump inhibitor as third-line treatment of Helicobacter pylori infection: A real-world clinical experience. J Gastroenterol Hepatol 2022;37:1928-34. [PMID: 35816187 DOI: 10.1111/jgh.15942] [Reference Citation Analysis]
|
| 25 |
Cao X, Du X, Jiao H, An Q, Chen R, Fang P, Wang J, Yu B. Carbohydrate-based drugs launched during 2000-2021. Acta Pharm Sin B 2022;12:3783-821. [PMID: 36213536 DOI: 10.1016/j.apsb.2022.05.020] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 26 |
Ivyna de Araújo Rêgo R, Guedes Silvestre GF, Ferreira de Melo D, Albino SL, Pimentel MM, Silva Costa Cruz SB, Silva Wurzba SD, Rodrigues WF, Goulart de Lima Damasceno BP, Cançado Castellano LR. Flavonoids-Rich Plant Extracts Against Helicobacter pylori Infection as Prevention to Gastric Cancer. Front Pharmacol 2022;13:951125. [DOI: 10.3389/fphar.2022.951125] [Reference Citation Analysis]
|
| 27 |
Nyssen OP, Moreira L, García-morales N, Cano-català A, Puig I, Mégraud F, O’morain C, Gisbert JP. European Registry on Helicobacter pylori Management (Hp-EuReg): Most relevant results for clinical practice. Front Gastroenterol 2022;1. [DOI: 10.3389/fgstr.2022.965982] [Reference Citation Analysis]
|
| 28 |
Reyes D, Ortiz J, Fuentes-lópez E, Budnik S, Gándara V, Gallardo A, Seydewitz MF, Candia R, Vargas JI, Rollan MP, Godoy J, Rollan A, Mansilla R, Arenas A, Chahuán J, Espino A, Pizarro M, Riquelme A. Quadruple therapies are superior to standard triple therapy for Helicobacter pylori first-line eradication in Chile. Gastroenterología y Hepatología (English Edition) 2022;45:515-523. [DOI: 10.1016/j.gastre.2022.07.004] [Reference Citation Analysis]
|
| 29 |
Inokuchi K, Mori H, Matsuzaki J, Hirata K, Harada Y, Saito Y, Suzuki H, Kanai T, Masaoka T. Efficacy and safety of low-dose rifabutin-based 7-day triple therapy as a third- or later-line Helicobacter pylori eradication regimen. Helicobacter 2022;27:e12900. [PMID: 35644041 DOI: 10.1111/hel.12900] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 30 |
Deng R, Zheng H, Cai H, Li M, Shi Y, Ding S. Effects of helicobacter pylori on tumor microenvironment and immunotherapy responses. Front Immunol 2022;13:923477. [DOI: 10.3389/fimmu.2022.923477] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 31 |
Chang CC, Jan HM, Tseng CJ, Mondal S, Abera AB, Hsieh MY, Yang TC, Muthusamy S, Huang SC, Lin CH, Tony Mong KK. Metabolic Isolation, Stereochemical Determination, and Total Synthesis of Predominant Native Cholesteryl Phosphatidyl-α-glucoside from Carcinogenic Helicobacter pylori. Org Lett 2022. [PMID: 35816729 DOI: 10.1021/acs.orglett.2c01815] [Reference Citation Analysis]
|
| 32 |
Alanli R, Küçükay MB. Helicobacter pylori eradikasyon tedavisinin tam kan sayımı ve inflamatuvar parametrelere etkisi. Akademik Gastroenteroloji Dergisi 2022. [DOI: 10.17941/agd.1106356] [Reference Citation Analysis]
|
| 33 |
Zhou Y, Zhong Z, Hu S, Wang J, Deng Y, Li X, Chen X, Li X, Tang Y, Li X, Hao Q, Liu J, Sang T, Bo Y, Bai F. A Survey of Helicobacter pylori Antibiotic-Resistant Genotypes and Strain Lineages by Whole-Genome Sequencing in China. Antimicrob Agents Chemother 2022;:e0218821. [PMID: 35652644 DOI: 10.1128/aac.02188-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 34 |
Civelek Z, Urgancı N, Usta M, Özgüven MB. Prevalence of <i>Helicobacter pylori</i> Infection in Pediatric Patients With Celiac Disease. cjms 2022;7:349-353. [DOI: 10.4274/cjms.2021.2021-50] [Reference Citation Analysis]
|
| 35 |
Saif N, Jensen N, Farrar E, Blackstone S, Hauck FR. Prevalence of Helicobacter pylori infection among resettled refugees presenting to a family medicine clinic in the United States. Helicobacter 2022;27:e12894. [PMID: 35484785 DOI: 10.1111/hel.12894] [Reference Citation Analysis]
|
| 36 |
Ansari S, Yamaoka Y. Animal Models and Helicobacter pylori Infection. J Clin Med 2022;11:3141. [PMID: 35683528 DOI: 10.3390/jcm11113141] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 37 |
Fei Y, Fang R, Xiao L, Zhang Y, Fan K, Jiang Y, Lei S, Xu R, Yang D, Ye Y, Xiang S, Wang P, Zhou C, Tang T. The development of a colorimetric biosensing assay for the detection of Helicobacter pylori in feces. Anal Biochem 2022;:114737. [PMID: 35595119 DOI: 10.1016/j.ab.2022.114737] [Reference Citation Analysis]
|
| 38 |
Meng F, Tao H, Mi Y, Yang T, Wang X, Go Y, Lin Y, Wang G. Nanocluster-mediated photothermia improves eradication efficiency and antibiotic sensitivity of Helicobacter pylori. Cancer Nano 2022;13. [DOI: 10.1186/s12645-022-00121-2] [Reference Citation Analysis]
|
| 39 |
Chen X, Zou Y, Zhang S, Fang P, Li S, Li P, Sun Y, Yuan G, Hu H. Multi-functional vesicles improve Helicobacter pylori eradication by a comprehensive strategy based on complex pathological microenvironment. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.05.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 40 |
Tanous O, Levin C, Suchdev PS, Luo H, Rinawi F. Resolution of iron deficiency following successful eradication of Helicobacter pylori in children. Acta Paediatr 2022;111:1075-82. [PMID: 35028968 DOI: 10.1111/apa.16255] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 41 |
Voss SJ, McGuinness DH, Weir W, Sutton DGM. A study comparing the healthy and diseased equine glandular gastric microbiota sampled with sheathed transendoscopic cytology brushes. J Equine Vet Sci 2022;:104002. [PMID: 35490972 DOI: 10.1016/j.jevs.2022.104002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 42 |
Knoop RF, Gaertner PC, Petzold G, Amanzada A, Ellenrieder V, Neesse A, Bremer SCB, Kunsch S, Mascellino MT. Systematic Retesting for Helicobacter pylori: The Potential Overestimation of Suppressive Conditions. BioMed Research International 2022;2022:1-6. [DOI: 10.1155/2022/5380001] [Reference Citation Analysis]
|
| 43 |
Ansari S, Yamaoka Y. Helicobacter pylori Infection, Its Laboratory Diagnosis, and Antimicrobial Resistance: a Perspective of Clinical Relevance. Clin Microbiol Rev 2022;:e0025821. [PMID: 35404105 DOI: 10.1128/cmr.00258-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 44 |
Assefa B, Tadesse A, Abay Z, Abebe A, Tesfaye T, Tadesse M, Molla A. Peptic ulcer disease among dyspeptic patients at endoscopy unit, University of Gondar hospital, Northwest Ethiopia. BMC Gastroenterol 2022;22:164. [PMID: 35382748 DOI: 10.1186/s12876-022-02245-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 45 |
Chang YW, Shin GY, Kim JW, Moon JC, Chang EJ, Oh CH, Jang JY. Cost-Effectiveness of Empirical Bismuth-Based Quadruple Therapy and Tailored Therapy After Clarithromycin Resistance Tests for Helicobacter pylori Eradication. Dig Dis Sci 2022;67:1222-30. [PMID: 33755825 DOI: 10.1007/s10620-021-06938-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 46 |
Guo Z, Tian S, Wang W, Zhang Y, Li J, Lin R. Correlation Analysis Among Genotype Resistance, Phenotype Resistance, and Eradication Effect After Resistance-Guided Quadruple Therapies in Refractory Helicobacter pylori Infections. Front Microbiol 2022;13:861626. [PMID: 35330762 DOI: 10.3389/fmicb.2022.861626] [Reference Citation Analysis]
|
| 47 |
Cui J, Hou S, Liu B, Yang M, Wei L, Du S, Li S. Species composition and overall diversity are significantly correlated between the tongue coating and gastric fluid microbiomes in gastritis patients. BMC Med Genomics 2022;15:60. [PMID: 35300688 DOI: 10.1186/s12920-022-01209-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 48 |
Zhong MF, Li J, Liu XL, Gong P, Zhang XT. TCM-Based Therapy as a Rescue Therapy for Re-Eradication of Helicobacter pylori Infection: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med 2022;2022:5626235. [PMID: 35251209 DOI: 10.1155/2022/5626235] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 49 |
Keikha M, Kamali H. The impact of Saccharomyces boulardii adjuvant supplementation on alternation of gut microbiota after H. pylori eradication; a metagenomics analysis. Gene Reports 2022;26:101499. [DOI: 10.1016/j.genrep.2022.101499] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 50 |
Merlotti D, Mingiano C, Valenti R, Cavati G, Calabrese M, Pirrotta F, Bianciardi S, Palazzuoli A, Gennari L. Bone Fragility in Gastrointestinal Disorders. Int J Mol Sci 2022;23:2713. [PMID: 35269854 DOI: 10.3390/ijms23052713] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 51 |
Mirzaei R, Sabokroo N, Ahmadyousefi Y, Motamedi H, Karampoor S. Immunometabolism in biofilm infection: lessons from cancer. Mol Med 2022;28. [DOI: 10.1186/s10020-022-00435-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 52 |
Brennan DE, O'Morain C, McNamara D, Smith SM. Combined antrum and corpus biopsy protocol improves Helicobacter pylori culture success. World J Gastrointest Pathophysiol 2022; 13(1): 34-40 [DOI: 10.4291/wjgp.v13.i1.34] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 53 |
Tilahun M, Gedefie A, Belayhun C, Sahle Z, Abera A. Helicobacter pylori Pathogenicity Islands and Giardia lamblia Cysteine Proteases in Role of Coinfection and Pathogenesis. Infect Drug Resist 2022;15:21-34. [PMID: 35023934 DOI: 10.2147/IDR.S346705] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 54 |
Harris RB, Brown HE, Begay RL, Sanderson PR, Chief C, Monroy FP, Oren E. Helicobacter pylori Prevalence and Risk Factors in Three Rural Indigenous Communities of Northern Arizona. Int J Environ Res Public Health 2022;19:797. [PMID: 35055622 DOI: 10.3390/ijerph19020797] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 55 |
Suzuki S, Kusano C, Horii T, Ichijima R, Ikehara H. The Ideal Helicobacter pylori Treatment for the Present and the Future. Digestion 2022;103:62-8. [PMID: 34662879 DOI: 10.1159/000519413] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 56 |
Kim J, Gong EJ, Seo M, Seo HI, Park JK, Lee SJ, Han KH, Jeong WJ, Kim YD, Cheon GJ. Efficacy of Twice a Day Bismuth Quadruple Therapy for Second-Line Treatment of Helicobacter pylori Infection. JPM 2022;12:56. [DOI: 10.3390/jpm12010056] [Reference Citation Analysis]
|
| 57 |
Sharndama HC, Mba IE. Helicobacter pylori: an up-to-date overview on the virulence and pathogenesis mechanisms. Braz J Microbiol 2022. [PMID: 34988937 DOI: 10.1007/s42770-021-00675-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
|
| 58 |
Shamsdin SA, Khazraei H, Rahimi Jaberi A, Zamani M, Rafiee Monjezi M. Evaluation of Inflammatory Cytokine and Anti Helicobacter Pylori Antibodies in the Pathogenesis of Parkinson's Disease. Middle East J Dig Dis 2022;14:96-102. [PMID: 36619735 DOI: 10.34172/mejdd.2022.261] [Reference Citation Analysis]
|
| 59 |
Kapfhammer H. Gastrointestinale Erkrankungen. Depression, Angst, traumatischer Stress und internistische Erkrankungen 2022. [DOI: 10.1007/978-3-662-65873-4_6] [Reference Citation Analysis]
|
| 60 |
Al-Zahrani MS, Alhassani AA, Zawawi KH. Clinical manifestations of gastrointestinal diseases in the oral cavity. Saudi Dent J 2021;33:835-41. [PMID: 34938023 DOI: 10.1016/j.sdentj.2021.09.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 61 |
Jiang W, Liu CH, Wu D, Wang YJ, Tang H. Abnormal transaminase and lipid profiles in coexisting diseases in patients with fatty liver: a population study in Sichuan. Biosci Rep 2021;41:BSR20211769. [PMID: 34918746 DOI: 10.1042/BSR20211769] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 62 |
Azami M, Baradaran HR, Dehghanbanadaki H, Kohnepoushi P, Saed L, Moradkhani A, Moradpour F, Moradi Y. Association of Helicobacter pylori infection with the risk of metabolic syndrome and insulin resistance: an updated systematic review and meta-analysis. Diabetol Metab Syndr 2021;13:145. [PMID: 34922625 DOI: 10.1186/s13098-021-00765-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 63 |
Avalueva EB, Serkova MY, Sitkin SI. <i>Helicobacter pylori</i>. The survival strategy of a commensal symbiont in the <i>Homo sapiens</i> population. jour 2021. [DOI: 10.31146/1682-8658-ecg-193-9-102-108] [Reference Citation Analysis]
|
| 64 |
Reyes D, Ortiz J, Fuentes-López E, Budnik S, Gandara V, Gallardo A, Seydewitz MF, Candia R, Ignacio Vargas J, Rollan MP, Godoy J, Rollan A, Mansilla R, Arenas A, Chahuán J, Espino A, Pizarro M, Riquelme A. Quadruple therapies are superior to standard triple therapy for Helicobacter pylori first-line eradication in Chile. Gastroenterol Hepatol 2021:S0210-5705(21)00320-4. [PMID: 34890721 DOI: 10.1016/j.gastrohep.2021.11.010] [Reference Citation Analysis]
|
| 65 |
Yan ZB, Zhang JY, Lv YP, Tian WQ, Shan ZG, Mao FY, Liu YG, Chen WY, Wang P, Yang Y, Cheng P, Peng LS, Liao YL, Yue GY, Xu XL, Zhao YL, Lü MH, Zhuang Y. Helicobacter pylori-induced REDD1 modulates Th17 cell responses that contribute to gastritis. Clin Sci (Lond) 2021;135:2541-58. [PMID: 34730176 DOI: 10.1042/CS20210753] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 66 |
Zhang L, Xiao Y, Ji L, Lin M, Zou Y, Zhao J, Zhao S. Potential Therapeutic Effects of Egg Yolk Antibody (IgY) in Helicobacter pylori Infections─A Review. J Agric Food Chem 2021;69:13691-9. [PMID: 34783242 DOI: 10.1021/acs.jafc.1c05398] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 67 |
Boonyabaramee P, Pittayanon R, Sunpavat A, Lerttanatum N, Faknak N, Wisedopas N. The Helicobacter pylori detection rate by using combination of rapid urease test at antrum and body vs histopathology in population who stop proton pump inhibitor less than 2 weeks. GastroHep 2021;3:339-343. [DOI: 10.1002/ygh2.496] [Reference Citation Analysis]
|
| 68 |
Seyedmajidi MR, Hosseini SA, Vafaeimanesh J. Comparing the Effect of Two Low-dose and High-dose Four-drug Regimens of Furazolidone in Eradicating Helicobacter Pylori. Middle East J Dig Dis 2021;13:131-8. [PMID: 34712451 DOI: 10.34172/mejdd.2021.216] [Reference Citation Analysis]
|
| 69 |
AlBalbeesi A, Alsalman H, Alotaibi H, Halawani M, Almukhadeb E, Alsaif F, Azzam N, AlKaff T, Aldosari M, Shadid A. Prevalence of Helicobacter pylori Infection Among Rosacea and Chronic Spontaneous Urticaria Patients in a Tertiary Hospital in Riyadh, Saudi Arabia. Cureus 2021;13:e17617. [PMID: 34646668 DOI: 10.7759/cureus.17617] [Reference Citation Analysis]
|
| 70 |
Mao LQ, Zhou YL, Wang SS, Chen L, Hu Y, Yu LM, Xu JM, Lyu B. Impact of Helicobacter pylori eradication on the gastric microbiome. Gut Pathog 2021;13:60. [PMID: 34645495 DOI: 10.1186/s13099-021-00460-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 71 |
Erkut M, Uzun DY, Kaklıkkaya N, Fidan S, Yoğun Y, Coşar AM, Akyıldız E, Topbaş M, Özgür O, Arslan M. Sociodemographic characteristics and clinical risk factors of Helicobacter pylori infection and antibiotic resistance in the Eastern Black Sea region of Turkey. Turk J Gastroenterol 2020;31:221-33. [PMID: 32343234 DOI: 10.5152/tjg.2020.18631] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 72 |
Xirouchakis E, Georgopoulos SD. Evaluating treatments with rifabutin and amoxicillin for eradication of Helicobacter pylori infection in adults: a systematic review. Expert Opin Pharmacother 2021;:1-10. [PMID: 34595999 DOI: 10.1080/14656566.2021.1982894] [Reference Citation Analysis]
|
| 73 |
Keshavarzi S, Sepehrimanesh M, Mirzaei B, Kuhi Hossein Abadi O, Sardari Z, Sajjadpur MM, Dept. of Microbiology, Fars Sciences and Research Branch, Islamic Azad University, Shiraz, Iran, Dept. of Biology, University of Louisiana at Lafayette, Louisiana, USA, Dept. of Medical Microbiology and Virology, Faculty of Medicine, Mazandaran University of Medical Science, Sari, Iran, Central Laboratory, Shiraz University of Medical Sciences, Shiraz, Iran, Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran, Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. Antimicrobial Effects of Aqueous and Hydro-Alcoholic Plantago psyllium leaf extracts on the Experimental Infection of Helicobacter pylori in a Rat Model. J Adv Med Biomed Res 2021;29:317-323. [DOI: 10.30699/jambs.29.137.317] [Reference Citation Analysis]
|
| 74 |
Durazzo M, Adriani A, Fagoonee S, Saracco GM, Pellicano R. Helicobacter pylori and Respiratory Diseases: 2021 Update. Microorganisms 2021;9:2033. [PMID: 34683354 DOI: 10.3390/microorganisms9102033] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 75 |
Chen LW, Chang LC, Hua CC, Liu CJ, Chou TS, Lin CL, Chien RN. The Application of High-Dose Proton Pump Inhibitor Induction Treatment before Dual Therapy for Helicobacter pylori Eradication: An Open-Label Random Trial. J Clin Med 2021;10:4352. [PMID: 34640370 DOI: 10.3390/jcm10194352] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 76 |
Cha B, Bang BW, Shin JB, Ko EJ, Ko W, Kwon KS, Shin YW, Suh YJ, Kim H. Bismuth containing quadruple therapy versus tailored therapy as first-line treatments for Helicobacter pylori infection in a high clarithromycin resistance area. Scand J Gastroenterol 2021;56:1017-22. [PMID: 34369255 DOI: 10.1080/00365521.2021.1948606] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 77 |
Meliț LE, Mărginean CO, Săsăran MO, Mocan S, Ghiga DV, Bogliş A, Duicu C. Innate immunity – the hallmark of Helicobacter pylori infection in pediatric chronic gastritis. World J Clin Cases 2021; 9(23): 6686-6697 [PMID: 34447815 DOI: 10.12998/wjcc.v9.i23.6686] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 78 |
Du L, Liu J, Jin C, Ma Y, Yin L, Man S, Li S, Li L, Ning Y, Zhang X. Association between Helicobacter pylori infection and carotid atherosclerosis in Chinese adults. Atheroscler Plus 2021;44:25-30. [PMID: 36644666 DOI: 10.1016/j.athplu.2021.08.004] [Reference Citation Analysis]
|
| 79 |
González-hormazábal P, Arenas A, Serrano C, Pizarro M, Fuentes-lópez E, Arnold J, Berger Z, Musleh M, Valladares H, Lanzarini E, Jara L, Castro VG, Camargo MC, Riquelme A. Prevalence of Helicobacter pylori Antimicrobial Resistance Among Chilean Patients. Archives of Medical Research 2021;52:529-34. [DOI: 10.1016/j.arcmed.2021.01.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 80 |
Gonzalez-Hormazabal P, Pelaez D, Musleh M, Bustamante M, Stambuk J, Pisano R, Valladares H, Lanzarini E, Chiong H, Suazo J, Quiñones LA, Varela NM, Castro VG, Jara L, Berger Z. NOD1 rs2075820 (p.E266K) polymorphism is associated with gastric cancer among individuals infected with cagPAI-positive H. pylori. Biol Res 2021;54:13. [PMID: 33879265 DOI: 10.1186/s40659-021-00336-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 81 |
Saracino IM, Pavoni M, Zullo A, Fiorini G, Lazzarotto T, Borghi C, Vaira D. Next Generation Sequencing for the Prediction of the Antibiotic Resistance in Helicobacter pylori: A Literature Review. Antibiotics (Basel) 2021;10:437. [PMID: 33919811 DOI: 10.3390/antibiotics10040437] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 82 |
Ozturk T, Sengul D, Sengul I. Helicobacter pylori and association between its positivity and anatomotopographic settlement in the stomach with the host age range. Ann Afr Med 2021;20:1-8. [PMID: 33727504 DOI: 10.4103/aam.aam_69_19] [Reference Citation Analysis]
|
| 83 |
Zhang L, Zhang L, Deng H, Li H, Tang W, Guan L, Qiu Y, Donovan MJ, Chen Z, Tan W. In vivo activation of pH-responsive oxidase-like graphitic nanozymes for selective killing of Helicobacter pylori. Nat Commun 2021;12:2002. [PMID: 33790299 DOI: 10.1038/s41467-021-22286-x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 19.0] [Reference Citation Analysis]
|
| 84 |
Zhang Q, Ni Y, Zhi X, Wang J, Li Z, Tang J, Wang L, Wang W, Xu Z. Involvement of APRIL in Helicobacter pylori-related gastric cancer. J Cancer Res Clin Oncol 2021;147:1685-97. [PMID: 33738544 DOI: 10.1007/s00432-021-03574-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 85 |
Scarpignato C, Hunt RH. Acid Suppressant Therapy: a Step Forward with Potassium-Competitive Acid Blockers. Curr Treat Options Gastro 2021;19:94-132. [DOI: 10.1007/s11938-020-00330-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 86 |
Reshetnyak VI, Burmistrov AI, Maev IV. Helicobacter pylori: Commensal, symbiont or pathogen? . World J Gastroenterol 2021; 27(7): 545-560 [PMID: 33642828 DOI: 10.3748/wjg.v27.i7.545] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 35] [Article Influence: 19.0] [Reference Citation Analysis]
|
| 87 |
Kang S, Kim Y, Ahn JY, Jung HY, Kim N, Na HK, Lee JH, Jung KW, Kim DH, Choi KD, Song HJ, Lee GH. Role of Antimicrobial Susceptibility Testing before First-Line Treatment Containing Clarithromycin for Helicobacter pylori Eradication in the Clinical Setting. Antibiotics (Basel) 2021;10:214. [PMID: 33669969 DOI: 10.3390/antibiotics10020214] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 88 |
Reshetnyak VI, Burmistrov AI, Maev IV. Helicobacter pylori: Commensal, symbiont or pathogen? World J Gastroenterol 2021;27:545-60. [PMID: 33642828 DOI: 10.3748/wjg.v27.i7.545] [Reference Citation Analysis]
|
| 89 |
Gebeyehu E, Nigatu D, Engidawork E. Complete symptom resolution as predictor of Helicobacter pylori eradication and factors affecting symptom resolution: Prospective follow up study. PLoS One 2021;16:e0246624. [PMID: 33571257 DOI: 10.1371/journal.pone.0246624] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 90 |
Li H, Xia XJ, Zhang LF, Chi JS, Liu P, Wu H, Xie XR, Tian DL, Kun KX, Gong RJ, Liu XM, Xu CX. Comparative study of allicin-containing quadruple therapy vs. bismuth-containing quadruple therapy for the treatment of Helicobacter pylori infection: a prospective randomized study. Eur J Gastroenterol Hepatol 2021;32:194-200. [PMID: 32804837 DOI: 10.1097/MEG.0000000000001896] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 91 |
Malli IA. From Inflammation to Cancer: Role of Genetic Polymorphisms of Inflammatory Pathway Molecules in Gastric Cancer. Genetic Polymorphism and cancer susceptibility 2021. [DOI: 10.1007/978-981-33-6699-2_4] [Reference Citation Analysis]
|
| 92 |
Wang J, Dong F, Su H, Zhu L, Shao S, Wu J, Liu H. H. pylori is related to NAFLD but only in female: A Cross-sectional Study. Int J Med Sci 2021;18:2303-11. [PMID: 33967606 DOI: 10.7150/ijms.50748] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 93 |
Istiaq A, Ishtiyaq Ahmad SA, Anam MB, Kudo M, Nakayama S, Ito N, Ohta K. Bacteria to form induced pluripotent stem cells. Methods in iPSC Technology 2021. [DOI: 10.1016/b978-0-323-85766-6.00013-9] [Reference Citation Analysis]
|
| 94 |
Gonciarz W, Lechowicz Ł, Urbaniak M, Kaca W, Chmiela M. Use of Fourier-Transform Infrared Spectroscopy (FT-IR) for Monitoring Experimental Helicobacter pylori Infection and Related Inflammatory Response in Guinea Pig Model. Int J Mol Sci 2020;22:E281. [PMID: 33396581 DOI: 10.3390/ijms22010281] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 95 |
Iqbal U, Khara HS, Akhtar D, Hu Y, Anwar H, Haq KF, Siddiqui HU, Bergenstock MK, Shellenberger MJ. Safety and Efficacy of Nitazoxanide-Based Regimen for the Eradication of Helicobacter pylori Infection: A Systematic Review and Meta-Analysis. Gastroenterology Res 2020;13:260-8. [PMID: 33447305 DOI: 10.14740/gr1342] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 96 |
Wu D, Sun Z, Li T, Tan Q, Sun Y, Chen T, Liu Y, Li J, Jiang H, Yuan Z, Zhao Y, Chen W. Efficacy of quadruple regimen with polaprezinc for gastric Helicobacter pylori infection eradication: protocol for a single-centre, single-blind, non-inferiority, randomised clinical trial. BMJ Open 2020;10:e037182. [PMID: 33203625 DOI: 10.1136/bmjopen-2020-037182] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 97 |
Xie J, Wen J, Chen C, Luo M, Hu B, Wu D, Ye J, Lin Y, Ning L, Ning Y, Li Y. Notch 1 Is Involved in CD4+ T Cell Differentiation Into Th1 Subtype During Helicobacter pylori Infection. Front Cell Infect Microbiol 2020;10:575271. [PMID: 33224898 DOI: 10.3389/fcimb.2020.575271] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 98 |
Noh CK, Lee GH, Park JW, Roh J, Han JH, Lee E, Park B, Lim SG, Shin SJ, Cheong JY, Kim JH, Lee KM. Diagnostic accuracy of "sweeping" method compared to conventional sampling in rapid urease test for Helicobacter pylori detection in atrophic mucosa. Sci Rep 2020;10:18483. [PMID: 33116260 DOI: 10.1038/s41598-020-75528-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 99 |
Açar S. Helikobakter Pylori Eradikasyonunda Modifiye Hibrit Tedavi Etkinliği. Zeynep Kamil Tıp Bülteni 2020. [DOI: 10.16948/zktipb.773921] [Reference Citation Analysis]
|
| 100 |
Kaipainen P, Kaski M. Helicobacter pylori Infection and Atrophic Corpus Gastritis on Patients with Intellectual Disability: Challenges in the Clinical Translation of Personalized Medicine. Personalized Medicine, in Relation to Redox State, Diet and Lifestyle 2020. [DOI: 10.5772/intechopen.73585] [Reference Citation Analysis]
|
| 101 |
Hirata Y, Yamada A, Niikura R, Shichijo S, Hayakawa Y, Koike K. Efficacy and safety of a new rifabutin-based triple therapy with vonoprazan for refractory Helicobacter pylori infection: A prospective single-arm study. Helicobacter 2020;25:e12719. [PMID: 32602161 DOI: 10.1111/hel.12719] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 102 |
Park CH. Changes in Gastric Microbial Composition before and after Helicobacter pylori Eradication Therapy. Korean J Helicobacter Up Gastrointest Res 2020;20:177-86. [DOI: 10.7704/kjhugr.2020.0028] [Reference Citation Analysis]
|
| 103 |
Erdogdu UE, Çayci H, Tardu A, Arslan U, Üstündağ Y, Erel Ö, Demirci H, Çantay H. Relationship between Helicobacter pylori and thiol-disulfide homeostasis: A prospective observational study. Archives of Clinical and Experimental Medicine 2020;5:38-42. [DOI: 10.25000/acem.635688] [Reference Citation Analysis]
|
| 104 |
Mohmmed Elhassan Ali Noor R, Mohammed Abdalla W, Abd Alla AB, Ibrahim Hashim A. Diagnosis of Helicobacter pylori infection using immunochromatography among patients attending Tamboul Hospital in Gezira State, Sudan: a cross-sectional study. F1000Res 2020;9:1054. [DOI: 10.12688/f1000research.25237.1] [Reference Citation Analysis]
|
| 105 |
Liu YG, Teng YS, Shan ZG, Cheng P, Hao CJ, Lv YP, Mao FY, Yang SM, Chen W, Zhao YL, You N, Zou QM, Zhuang Y. Arrestin domain containing 3 promotes Helicobacter pylori-associated gastritis by regulating protease-activated receptor 1. JCI Insight 2020;5:135849. [PMID: 32634127 DOI: 10.1172/jci.insight.135849] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 106 |
Wu Y, Su T, Zhou X, Lu N, Li Z, Du Y. Awareness and attitudes regarding Helicobacter pylori infection in Chinese physicians and public population: A national cross-sectional survey. Helicobacter 2020;25:e12705. [PMID: 32476197 DOI: 10.1111/hel.12705] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 107 |
Kim SY, Chung JW. Best Helicobacter pylori Eradication Strategy in the Era of Antibiotic Resistance. Antibiotics (Basel) 2020;9:E436. [PMID: 32717826 DOI: 10.3390/antibiotics9080436] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 108 |
Altamimi E, Alsharkhat N, AlJawarneh A, Abu Hamad MDR, Assi AA, Alawneh S, Al-Ahmad M. Declining prevalence of Helicobacter pylori infection in Jordanian children, report from developing country. Heliyon 2020;6:e04416. [PMID: 32715122 DOI: 10.1016/j.heliyon.2020.e04416] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 109 |
Kuo CJ, Lin CY, Le PH, Chang PY, Lai CH, Lin WR, Chang ML, Hsu JT, Cheng HT, Tseng CN, Lin CJ, Su MY, Hsieh SY, Chiu CT. Rescue therapy with rifabutin regimen for refractory Helicobacter pylori infection with dual drug-resistant strains. BMC Gastroenterol 2020;20:218. [PMID: 32650737 DOI: 10.1186/s12876-020-01370-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 110 |
Alzoubi H, Al-Mnayyis A, Al Rfoa I, Aqel A, Abu-Lubad M, Hamdan O, Jaber K. The Use of 13C-Urea Breath Test for Non-Invasive Diagnosis of Helicobacter pylori Infection in Comparison to Endoscopy and Stool Antigen Test. Diagnostics (Basel) 2020;10:E448. [PMID: 32635179 DOI: 10.3390/diagnostics10070448] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 111 |
Chen C, Zhang C, Wang X, Zhang F, Zhang Z, Ma P, Feng S. Helicobacter pylori infection may increase the severity of nonalcoholic fatty liver disease via promoting liver function damage, glycometabolism, lipid metabolism, inflammatory reaction and metabolic syndrome. Eur J Gastroenterol Hepatol 2020;32:857-66. [PMID: 31714387 DOI: 10.1097/MEG.0000000000001601] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 112 |
Marsilio I, Maddalo G, Ghisa M, Savarino EV, Farinati F, Zingone F. The coeliac stomach: A review of the literature. Dig Liver Dis 2020;52:615-24. [PMID: 32295740 DOI: 10.1016/j.dld.2020.03.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 113 |
Yoon K, Kim N, Lee JW, Yoon H, Shin CM, Park YS, Lee DH. Annual eradication rate of bismuth-containing quadruple therapy as second-line treatment for Helicobacter pylori infection: A 15-year prospective study at a tertiary hospital in Korea. Helicobacter 2020;25:e12685. [PMID: 32141173 DOI: 10.1111/hel.12685] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 114 |
Namdari S, Nicholson T, Abboud J, Lazarus M, Ramsey ML, Williams G, Parvizi J. Cutibacterium acnes is less commonly identified by next-generation sequencing than culture in primary shoulder surgery. Shoulder Elbow 2020;12:170-7. [PMID: 32565918 DOI: 10.1177/1758573219842160] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 115 |
Aumpan N, Vilaichone RK, Gamnarai P, Sanglutong L, Ratanachu-Ek T, Mahachai V, Yamaoka Y. Prevalence and Antibiotic Resistance Patterns of Helicobacter pylori Infection in Koh Kong, Cambodia. Asian Pac J Cancer Prev 2020;21:1409-13. [PMID: 32458649 DOI: 10.31557/APJCP.2020.21.5.1409] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 116 |
Kim YA, Cho YJ, Kwak SG. The Association between Helicobacter pylori Infection and Irritable Bowel Syndrome: A Meta-Analysis. Int J Environ Res Public Health 2020;17:E2524. [PMID: 32272678 DOI: 10.3390/ijerph17072524] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 117 |
Venero-fernández S, Avila-ochoa I, Menocal-herredia L, Caraballo-sánchez Y, Rosado-garcía F, Suárez-medina R, Varona-pérez P, Fogarty A. Prevalence of and factors associated with Helicobacter pylori infection in preschoolers in Havana, Cuba: A population-based study. Revista de Gastroenterología de México (English Edition) 2020;85:151-159. [DOI: 10.1016/j.rgmxen.2019.03.010] [Reference Citation Analysis]
|
| 118 |
Vilaichone RK, Aumpan N, Ratanachu-Ek T, Gamnarai P, Uchida T, Tshering L, Mahachai V, Yamaoka Y. Efficacy of Omeprazole, Tetracycline, and 4 Times Daily Dosing of Amoxicillin in Helicobacter pylori Eradication in Limited Resource Area in Bhutan: A Prospective Randomized Trial (BHUTAN Study). Asian Pac J Cancer Prev 2020;21:1109-14. [PMID: 32334478 DOI: 10.31557/APJCP.2020.21.4.1109] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 119 |
Tayseer I, Aburjai T, Abu-qatouseh L, Al-karabieh N, Ahmed W, Al-samydai A; Department of Pharmaceutical Sciences, Faculty of Pharmacy, University of Jordan, Amman, Jordan., Department of Pharmaceutical Sciences, Faculty of Pharmacy, University of Jordan, Amman, Jordan., Faculty of Pharmacy, Department of Biomedical Sciences, University of Petra, Amman, Jordan., Department of Plant Protection, School of Agriculture, The University of Jordan, Amman, Jordan., Department of Pharmaceutical Sciences, Faculty of Pharmacy, University of Jordan, Amman, Jordan., Department of Pharmaceutical Sciences, Faculty of Pharmacy, University of Jordan, Amman, Jordan. In vitro Anti-Helicobacter pylori Activity of Capsaicin. J Pure Appl Microbiol 2020;14:279-86. [DOI: 10.22207/jpam.14.1.29] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 120 |
Saracino IM, Pavoni M, Zullo A, Fiorini G, Saccomanno L, Lazzarotto T, Cavallo R, Antonelli G, Vaira D. Antibiotic Resistance and Therapy Outcome in H. pylori Eradication Failure Patients. Antibiotics (Basel) 2020;9:E121. [PMID: 32183165 DOI: 10.3390/antibiotics9030121] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 121 |
Saranathan R, Levi MH, Wattam AR, Malek A, Asare E, Behin DS, Pan DH, Jacobs WR Jr, Szymczak WA. Helicobacter pylori Infections in the Bronx, New York: Surveying Antibiotic Susceptibility and Strain Lineage by Whole-Genome Sequencing. J Clin Microbiol 2020;58:e01591-19. [PMID: 31801839 DOI: 10.1128/JCM.01591-19] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 122 |
Papastergiou J, Donnelly M, Yuen T, Li W, van den Bemt B. Community pharmacy-based H. pylori screening for patients with uninvestigated dyspepsia. Can Pharm J (Ott) 2020;153:101-7. [PMID: 32206155 DOI: 10.1177/1715163520903065] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 123 |
Khien VV, Thang DM, Hai TM, Duat NQ, Khanh PH, Ha DT, Binh TT, Dung HDQ, Trang TTH, Yamaoka Y. Management of Antibiotic-Resistant Helicobacter pylori Infection: Perspectives from Vietnam. Gut Liver 2019;13:483-97. [PMID: 31009957 DOI: 10.5009/gnl18137] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 124 |
Meier HCS, Miller FW, Dinse GE, Weinberg CR, Cho CC, Parks CG. Helicobacter pylori seropositivity is associated with antinuclear antibodies in US adults, NHANES 1999-2000. Epidemiol Infect 2020;148:e20. [PMID: 32019616 DOI: 10.1017/S0950268820000126] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 125 |
Chen MJ, Fang YJ, Wu MS, Chen CC, Chen YN, Yu CC, Kuo CC, Chiu MC, Hu WH, Tsai MH, Hsieh CL, Chen HH, Bair MJ, Liou JM; Taiwan Gastrointestinal Disease and Helicobacter Consortium. Application of Helicobacter pylori stool antigen test to survey the updated prevalence of Helicobacter pylori infection in Taiwan. J Gastroenterol Hepatol 2020;35:233-40. [PMID: 31408909 DOI: 10.1111/jgh.14828] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 126 |
Zhang Y, Wen Y, Xiao Q, Zheng W, Long G, Chen B, Shu X, Jiang M. Mutations in the Antibiotic Target Genes Related to Clarithromycin, Metronidazole and Levofloxacin Resistance in Helicobacter pylori Strains from Children in China. Infect Drug Resist 2020;13:311-22. [PMID: 32099422 DOI: 10.2147/IDR.S235615] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 127 |
Milivojevic V, Milosavljevic T. Burden of Gastroduodenal Diseases from the Global Perspective. Curr Treat Options Gastroenterol 2020. [PMID: 31993967 DOI: 10.1007/s11938-020-00277-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 128 |
Saracino IM, Fiorini G, Zullo A, Pavoni M, Saccomanno L, Vaira D. Trends in Primary Antibiotic Resistance in H. pylori Strains Isolated in Italy between 2009 and 2019. Antibiotics (Basel) 2020;9:E26. [PMID: 31941121 DOI: 10.3390/antibiotics9010026] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 129 |
Kikuchi S, Nobeyama Y, Saeki H, Asahina A. Characteristics of cutaneous adverse drug reactions caused by triple-combination drug therapy used for Helicobacter pylori eradication. J Dermatol 2020;47:277-82. [PMID: 31912576 DOI: 10.1111/1346-8138.15208] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 130 |
Chen J, Ma J, Liu X, Duan S, Liang N, Yao S. The association between Helicobacter pylori infection with overweight/obesity: A protocol for a systematic review and meta-analysis of observational studies. Medicine (Baltimore) 2020;99:e18703. [PMID: 32011445 DOI: 10.1097/MD.0000000000018703] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 131 |
Kumar S, Maurya VK, Saxena SK. Emerging and Re-emerging Water-Associated Infectious Diseases. Water-Associated Infectious Diseases 2020. [DOI: 10.1007/978-981-13-9197-2_5] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 132 |
Arenas A, Serrano C, Quiñones L, Harris P, Sandoval M, Lavanderos M, Sepúlveda R, Maquilón S, Echeverría A, Ríos C, Fuentes-López E, Rojas L, Jorquera A, Pizarro M, Camargo MC, Riquelme A. High prevalence of clarithromycin resistance and effect on Helicobacter pylori eradication in a population from Santiago, Chile: cohort study and meta-analysis. Sci Rep 2019;9:20070. [PMID: 31882676 DOI: 10.1038/s41598-019-56399-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 133 |
Chang YW, Park YM, Oh CH, Oh SJ, Cho JH, Kim JW, Jang JY. Effects of probiotics or broccoli supplementation on Helicobacter pylori eradication with standard clarithromycin-based triple therapy. Korean J Intern Med 2020;35:574-81. [PMID: 31830776 DOI: 10.3904/kjim.2019.139] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 134 |
Dehdashtian E, Tabatabaeian H, Ghaedi K, Talebi A, Adami B. A H. pylori-independent miR-21 overexpression in gastric cancer patients. Gene Reports 2019;17:100528. [DOI: 10.1016/j.genrep.2019.100528] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 135 |
Gebeyehu E, Nigatu D, Engidawork E. Self-reported adverse drug effects and associated factors among H. pylori infected patients on standard triple therapy: Prospective follow up study. PLoS One 2019;14:e0225585. [PMID: 31756217 DOI: 10.1371/journal.pone.0225585] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 136 |
Fan CC, Chen CH, Chou C, Kao TY, Cheng AN, Lee AY, Kuo CL. A time-saving-modified Giemsa stain is a better diagnostic method of Helicobacter pylori infection compared with the rapid urease test. J Clin Lab Anal 2020;34:e23110. [PMID: 31733007 DOI: 10.1002/jcla.23110] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 137 |
Kane-dumbre S, Momin M, Ravikumar P, Khatri R, RK University, Rajkot- 360 028, Gujarat, India. DRUG DELIVERY STRATEGIES FOR HELICOBACTER PYLORI INFECTION MANAGEMENT: AN OVERVIEW. IND DRU 2019;56:7-21. [DOI: 10.53879/id.56.10.11811] [Reference Citation Analysis]
|
| 138 |
Morilla AM, Álvarez-argüelles ME, Duque JM, Armesto E, Villar H, Melón S. Primary antimicrobial resistance rates and prevalence of Helicobacter pylori infection in the north of Spain. A 13-year retrospective study. Gastroenterología y Hepatología (English Edition) 2019;42:476-485. [DOI: 10.1016/j.gastre.2019.05.003] [Reference Citation Analysis]
|
| 139 |
Kapizioni C, Koutoufaris G, Ntouli V, Makris K, Milioni K, Kourkoulis P, Giannelis P, Mellos A, Michalopoulos G, Vrakas S, Xourgias V. Optimal duration of concomitant nonbismuth quadruple therapy as first-line therapy for Helicobacter pylori: a prospective, open-label, comparative study. Eur J Gastroenterol Hepatol 2019;31:1206-10. [PMID: 31441794 DOI: 10.1097/MEG.0000000000001517] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 140 |
Alsamman MA, Vecchio EC, Shawwa K, Acosta-Gonzales G, Resnick MB, Moss SF. Retrospective Analysis Confirms Tetracycline Quadruple as Best Helicobacter pylori Regimen in the USA. Dig Dis Sci 2019;64:2893-8. [PMID: 31187323 DOI: 10.1007/s10620-019-05694-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 141 |
Chen X, Wong CH, Ma C. Targeting the Bacterial Transglycosylase: Antibiotic Development from a Structural Perspective. ACS Infect Dis 2019;5:1493-504. [PMID: 31283163 DOI: 10.1021/acsinfecdis.9b00118] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 142 |
Clyne M, May FEB. The Interaction of Helicobacter pylori with TFF1 and Its Role in Mediating the Tropism of the Bacteria Within the Stomach. Int J Mol Sci 2019;20:E4400. [PMID: 31500233 DOI: 10.3390/ijms20184400] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 143 |
Lim SH, Kim N, Kwon JW, Kim SE, Baik GH, Lee JY, Park KS, Shin JE, Song HJ, Myung DS, Choi SC, Kim HJ, Lim JH, Yim JY, Kim JS. Positive Association Between Helicobacter pylori Infection and Metabolic Syndrome in a Korean Population: A Multicenter Nationwide Study. Dig Dis Sci 2019;64:2219-30. [PMID: 30852768 DOI: 10.1007/s10620-019-05544-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 144 |
Yamamura K, Izumi D, Kandimalla R, Sonohara F, Baba Y, Yoshida N, Kodera Y, Baba H, Goel A. Intratumoral Fusobacterium Nucleatum Levels Predict Therapeutic Response to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma. Clin Cancer Res 2019;25:6170-9. [PMID: 31358543 DOI: 10.1158/1078-0432.CCR-19-0318] [Cited by in Crossref: 50] [Cited by in F6Publishing: 55] [Article Influence: 12.5] [Reference Citation Analysis]
|
| 145 |
Escobedo-belloc M, Bosques-padilla F. The rise of antibiotic resistance to Helicobacter pylori in Mexico: Is azithromycin plus levofloxacin the answer? Revista de Gastroenterología de México (English Edition) 2019;84:271-273. [DOI: 10.1016/j.rgmxen.2018.10.006] [Reference Citation Analysis]
|
| 146 |
Escobedo-belloc M, Bosques-padilla F. El incremento en la resistencia de Helicobacter pylori a los antibióticos en México: ¿son la azitromicina más levofloxacina la respuesta? Revista de Gastroenterología de México 2019;84:271-273. [DOI: 10.1016/j.rgmx.2018.10.005] [Reference Citation Analysis]
|
| 147 |
Limphaibool N, Iwanowski P, Holstad MJV, Kobylarek D, Kozubski W. Infectious Etiologies of Parkinsonism: Pathomechanisms and Clinical Implications. Front Neurol 2019;10:652. [PMID: 31275235 DOI: 10.3389/fneur.2019.00652] [Cited by in Crossref: 65] [Cited by in F6Publishing: 68] [Article Influence: 16.3] [Reference Citation Analysis]
|
| 148 |
Gebeyehu E, Nigatu D, Engidawork E. Helicobacter pylori eradication rate of standard triple therapy and factors affecting eradication rate at Bahir Dar city administration, Northwest Ethiopia: A prospective follow up study. PLoS One 2019;14:e0217645. [PMID: 31163069 DOI: 10.1371/journal.pone.0217645] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 149 |
P. V S, Chirukandath R, M. G, M. V. PREVALENCE OF HELICOBACTER PYLORI INFECTION IN GASTRIC CANCER IN PATIENTS ATTENDING A TERTIARY REFERRAL UNIT: A CROSS SECTIONAL STUDY. jebmh 2019;6:1589-1592. [DOI: 10.18410/jebmh/2019/321] [Reference Citation Analysis]
|
| 150 |
Baylina M, Muñoz N, Sánchez-Delgado J, López-Góngora S, Calvet X, Puig I. Systematic review: Would susceptibility-guided treatment achieve acceptable cure rates for second-line Helicobacter pylori therapy as currently practiced? Helicobacter 2019;24:e12584. [PMID: 30990575 DOI: 10.1111/hel.12584] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 151 |
Guo L, Hong D, Wang S, Zhang F, Tang F, Wu T, Chu Y, Liu H, He M, Yang H, Yin R, Liu K. Therapeutic Protection Against H. pylori Infection in Mongolian Gerbils by Oral Immunization With a Tetravalent Epitope-Based Vaccine With Polysaccharide Adjuvant. Front Immunol 2019;10:1185. [PMID: 31191547 DOI: 10.3389/fimmu.2019.01185] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 152 |
Aumpan N, Vilaichone RK, Chotivitayatarakorn P, Pornthisarn B, Cholprasertsuk S, Bhanthumkomol P, Kanokwanvimol A, Siramolpiwat S, Mahachai V. High Efficacy of Rapid Urine Test for Diagnosis of Helicobacter pylori Infection in Thai People. Asian Pac J Cancer Prev 2019;20:1525-9. [PMID: 31128058 DOI: 10.31557/APJCP.2019.20.5.1525] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 153 |
Suzuki S, Esaki M, Kusano C, Ikehara H, Gotoda T. Development of Helicobacter pylori treatment: How do we manage antimicrobial resistance? World J Gastroenterol 2019; 25(16): 1907-1912 [PMID: 31086459 DOI: 10.3748/wjg.v25.i16.1907] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 47] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 154 |
Yu Y, Cai J, Song Z, Wang J, Wu L. Association of Helicobacter pylori infection with metabolic syndrome in aged Chinese females. Exp Ther Med 2019;17:4403-8. [PMID: 31105780 DOI: 10.3892/etm.2019.7509] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 155 |
Uribe Pérez CJ, Amado Niño AM, Rueda Patiño AM, Mantilla Villabona LY. Barreras para la atención en salud del cáncer gástrico, Santander, Colombia. Etapa exploratoria. Rev Colomb Gastroenterol 2019;34:17. [DOI: 10.22516/25007440.353] [Reference Citation Analysis]
|
| 156 |
Meliț LE, Mărginean CO, Mărginean CD, Mărginean MO. The Relationship between Toll-like Receptors and Helicobacter pylori-Related Gastropathies: Still a Controversial Topic. J Immunol Res 2019;2019:8197048. [PMID: 30863783 DOI: 10.1155/2019/8197048] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 157 |
Karmakar P, Gaitonde V. Promising Recent Strategies with Potential Clinical Translational Value to Combat Antibacterial Resistant Surge. Medicines (Basel) 2019;6:E21. [PMID: 30709019 DOI: 10.3390/medicines6010021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 158 |
Smith SM, O'Morain C, McNamara D. Helicobacter pylori resistance to current therapies. Curr Opin Gastroenterol 2019;35:6-13. [PMID: 30489412 DOI: 10.1097/MOG.0000000000000497] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 159 |
Torbenson M. Common Types of Gastritis. Surgical Pathology of Non-neoplastic Gastrointestinal Diseases 2019. [DOI: 10.1007/978-3-030-15573-5_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 160 |
Qin XR, Wu J, Yao XY, Huang J, Wang XY. Helicobacter pylori DNA promotes cellular proliferation, migration, and invasion of gastric cancer by activating toll-like receptor 9. Saudi J Gastroenterol 2019;25:181-7. [PMID: 30618438 DOI: 10.4103/sjg.SJG_309_18] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 161 |
Monteiro JRB, Ardisson JS, Athaydes BR, Gonçalves RDCR, Rodrigues RP, Kuster RM, Kitagawa RR. Anti-Helicobacter pylori and Anti-inflammatory Properties of Eugenia uniflora L. Braz arch biol technol 2019;62:e19180285. [DOI: 10.1590/1678-4324-2019180285] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 162 |
Bakırcı Üreyen S, Efe C, Nasıroğlu İmga N, Köseoğlu T, Özaslan E, Tunca H, Sennaroğlu E. Helicobacter pylori CagA IgG pozitifliğinin gastrointestinal yakınmalar ve histopatolojik bulgular ile ilişkisi. Akademik Gastroenteroloji Dergisi 2018. [DOI: 10.17941/agd.469636] [Reference Citation Analysis]
|
| 163 |
Scida S, Russo M, Miraglia C, Leandro G, Franzoni L, Meschi T, De' Angelis GL, Di Mario F. Relationship between Helicobacter pylori infection and GERD. Acta Biomed 2018;89:40-3. [PMID: 30561416 DOI: 10.23750/abm.v89i8-S.7918] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
|
| 164 |
Muñoz N, Sánchez-delgado J, Baylina M, López-góngora S, Calvet X. Prevalence of Helicobacter pylori resistance after failure of first-line therapy. A systematic review. Gastroenterología y Hepatología (English Edition) 2018;41:654-662. [DOI: 10.1016/j.gastre.2018.11.021] [Reference Citation Analysis]
|
| 165 |
Feder R, Posner S, Qin Y, Zheng J, Chow SC, Garman KS. Helicobacter pylori-associated peptic ulcer disease: A retrospective analysis of post-treatment testing practices. Helicobacter 2018;23:e12540. [PMID: 30246287 DOI: 10.1111/hel.12540] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 166 |
Yang-Ou YB, Hu Y, Zhu Y, Lu NH. The effect of antioxidants on Helicobacter pylori eradication: A systematic review with meta-analysis. Helicobacter 2018;23:e12535. [PMID: 30191635 DOI: 10.1111/hel.12535] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 167 |
Doorakkers E, Lagergren J, Engstrand L, Brusselaers N. Helicobacter pylori eradication treatment and the risk of gastric adenocarcinoma in a Western population. Gut 2018;67:2092-6. [PMID: 29382776 DOI: 10.1136/gutjnl-2017-315363] [Cited by in Crossref: 74] [Cited by in F6Publishing: 74] [Article Influence: 14.8] [Reference Citation Analysis]
|
| 168 |
Cui J, Cui H, Yang M, Du S, Li J, Li Y, Liu L, Zhang X, Li S. Tongue coating microbiome as a potential biomarker for gastritis including precancerous cascade. Protein Cell 2019;10:496-509. [PMID: 30478535 DOI: 10.1007/s13238-018-0596-6] [Cited by in Crossref: 34] [Cited by in F6Publishing: 40] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 169 |
Khadka P, Chapagain G, Maharjan G, Paudyal P. A comparison of techniques to address the frequency of Helicobacter pylori positive dyspeptic patient. BMC Res Notes 2018;11:784. [PMID: 30390715 DOI: 10.1186/s13104-018-3897-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 170 |
Lim SH, Kim N, Kwon JW, Kim SE, Baik GH, Lee JY, Park KS, Shin JE, Song HJ, Myung DS, Choi SC, Kim HJ, Yim JY, Kim JS. Trends in the seroprevalence of Helicobacter pylori infection and its putative eradication rate over 18 years in Korea: A cross-sectional nationwide multicenter study. PLoS One 2018;13:e0204762. [PMID: 30332428 DOI: 10.1371/journal.pone.0204762] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 8.4] [Reference Citation Analysis]
|
| 171 |
Liou JM, Chen PY, Luo JC, Lee JY, Chen CC, Fang YJ, Yang TH, Chang CY, Bair MJ, Chen MJ, Hsu YC, Hsu WF, Chang CC, Lin JT, Shun CT, El-Omar EM, Wu MS; Taiwan Gastrointestinal Disease and Helicobacter Consortium. Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection. Gastroenterology 2018;155:1109-19. [PMID: 29964036 DOI: 10.1053/j.gastro.2018.06.047] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 10.4] [Reference Citation Analysis]
|
| 172 |
Jung JH, Cho IK, Lee CH, Song GG, Lim JH. Clinical Outcomes of Standard Triple Therapy Plus Probiotics or Concomitant Therapy for Helicobacter pylori Infection. Gut Liver 2018;12:165-72. [PMID: 29212313 DOI: 10.5009/gnl17177] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 173 |
Ozaki H, Harada S, Takeuchi T, Kawaguchi S, Takahashi Y, Kojima Y, Ota K, Hongo Y, Ashida K, Sakaguchi M, Tokioka S, Sakamoto H, Furuta T, Tominaga K, Higuchi K. Vonoprazan, a Novel Potassium-Competitive Acid Blocker, Should Be Used for the Helicobacter pylori Eradication Therapy as First Choice: A Large Sample Study of Vonoprazan in Real World Compared with Our Randomized Control Trial Using Second-Generation Proton Pump Inhibitors for Helicobacter pylori Eradication Therapy. Digestion 2018;97:212-8. [PMID: 29393194 DOI: 10.1159/000485097] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 174 |
An Y, Wang Y, Wu S, Wang YH, Qian X, Li Z, Fu YJ, Xie Y. Fourth-generation quinolones in the treatment of Helicobacter pylori infection: A meta-analysis. World J Gastroenterol 2018; 24(29): 3302-3312 [PMID: 30090010 DOI: 10.3748/wjg.v24.i29.3302] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 175 |
Nam K, Shin JE, Kim SE, Baik GH, Choi SH, Lee JY, Park KS, Joo YE, Myung DS, Kim HJ, Song HJ, Choi SC, Kim HJ, Kim HY, Kim N. Prevalence and risk factors for upper gastrointestinal diseases in health check-up subjects: a nationwide multicenter study in Korea. Scand J Gastroenterol 2018;53:910-6. [PMID: 30169983 DOI: 10.1080/00365521.2018.1487992] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 176 |
Li M, Oshima T, Horikawa T, Tozawa K, Tomita T, Fukui H, Watari J, Miwa H. Systematic review with meta-analysis: Vonoprazan, a potent acid blocker, is superior to proton-pump inhibitors for eradication of clarithromycin-resistant strains of Helicobacter pylori. Helicobacter 2018;23:e12495. [PMID: 29873436 DOI: 10.1111/hel.12495] [Cited by in Crossref: 61] [Cited by in F6Publishing: 55] [Article Influence: 12.2] [Reference Citation Analysis]
|
| 177 |
Park CG, Kim S, Lee EJ, Jeon HS, Han S. Clinical relevance of point mutations in the 23S rRNA gene in Helicobacter pylori eradication: A prospective, observational study. Medicine (Baltimore) 2018;97:e11835. [PMID: 30113472 DOI: 10.1097/MD.0000000000011835] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 178 |
Cisarò F, Pizzol A, Pinon M, Calvo PL. Diagnosis and treatment of Helicobacter pylori in the pediatric population. Minerva Pediatr 2018;70:476-87. [PMID: 30021412 DOI: 10.23736/S0026-4946.18.05346-X] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 179 |
Li Z, Lee K, Karagas MR, Madan JC, Hoen AG, O'Malley AJ, Li H. Conditional Regression Based on a Multivariate Zero-Inflated Logistic-Normal Model for Microbiome Relative Abundance Data. Stat Biosci 2018;10:587-608. [PMID: 30923584 DOI: 10.1007/s12561-018-9219-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 180 |
Tonkic A, Vukovic J, Vrebalov Cindro P, Pesutic Pisac V, Tonkic M. Diagnosis of Helicobacter pylori infection : A short review. Wien Klin Wochenschr 2018;130:530-4. [PMID: 29959527 DOI: 10.1007/s00508-018-1356-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 181 |
Chang YW, Ko WJ, Oh CH, Park YM, Oh SJ, Moon JR, Cho JH, Kim JW, Jang JY. Clarithromycin resistance and female gender affect Helicobacter pylori eradication failure in chronic gastritis. Korean J Intern Med 2019;34:1022-9. [PMID: 29898576 DOI: 10.3904/kjim.2018.054] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 182 |
Mori N, Nishiura Y, Suga D, Moritani I, Yamanaka Y, Ooya Y, Inoue H, Takase K, Hioki M, Shiraki K. Second-line triple therapy in failures with vonoprazan-based triple therapy for eradication of Helicobacter pylori. Biomed Rep 2018;9:169-74. [PMID: 30013779 DOI: 10.3892/br.2018.1111] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 183 |
Muñoz N, Sánchez-Delgado J, Baylina M, Puig I, López-Góngora S, Suarez D, Calvet X. Systematic review, meta-analysis, and meta-regression: Successful second-line treatment for Helicobacter pylori. Helicobacter 2018;23:e12488. [PMID: 29663581 DOI: 10.1111/hel.12488] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 184 |
Bilen M, Dufour JC, Lagier JC, Cadoret F, Daoud Z, Dubourg G, Raoult D. The contribution of culturomics to the repertoire of isolated human bacterial and archaeal species. Microbiome 2018;6:94. [PMID: 29793532 DOI: 10.1186/s40168-018-0485-5] [Cited by in Crossref: 91] [Cited by in F6Publishing: 94] [Article Influence: 18.2] [Reference Citation Analysis]
|
| 185 |
Ge Z, Sheh A, Feng Y, Muthupalani S, Ge L, Wang C, Kurnick S, Mannion A, Whary MT, Fox JG. Helicobacter pylori-infected C57BL/6 mice with different gastrointestinal microbiota have contrasting gastric pathology, microbial and host immune responses. Sci Rep 2018;8:8014. [PMID: 29789574 DOI: 10.1038/s41598-018-25927-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 186 |
Hathroubi S, Servetas SL, Windham I, Merrell DS, Ottemann KM. Helicobacter pylori Biofilm Formation and Its Potential Role in Pathogenesis. Microbiol Mol Biol Rev 2018;82:e00001-18. [PMID: 29743338 DOI: 10.1128/MMBR.00001-18] [Cited by in Crossref: 77] [Cited by in F6Publishing: 79] [Article Influence: 15.4] [Reference Citation Analysis]
|
| 187 |
Angsantikul P, Thamphiwatana S, Zhang Q, Spiekermann K, Zhuang J, Fang RH, Gao W, Obonyo M, Zhang L. Coating nanoparticles with gastric epithelial cell membrane for targeted antibiotic delivery against Helicobacter pylori infection. Adv Ther (Weinh) 2018;1:1800016. [PMID: 30320205 DOI: 10.1002/adtp.201800016] [Cited by in Crossref: 67] [Cited by in F6Publishing: 73] [Article Influence: 13.4] [Reference Citation Analysis]
|
| 188 |
Wang XY, Chen SH, Zhang YN, Xu CF. Olfactomedin-4 in digestive diseases: A mini-review. World J Gastroenterol 2018; 24(17): 1881-1887 [PMID: 29740203 DOI: 10.3748/wjg.v24.i17.1881] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 189 |
Yu HC, Chen TP, Wei CY, Chang YC. Association between Peptic Ulcer Disease and Periodontitis: A Nationwide Population-Based Case-Control Study in Taiwan. Int J Environ Res Public Health 2018;15:E912. [PMID: 29734656 DOI: 10.3390/ijerph15050912] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 190 |
Gatta L, Scarpignato C, Fiorini G, Belsey J, Saracino IM, Ricci C, Vaira D. Impact of primary antibiotic resistance on the effectiveness of sequential therapy for Helicobacter pylori infection: lessons from a 5-year study on a large number of strains. Aliment Pharmacol Ther 2018;47:1261-9. [PMID: 29536561 DOI: 10.1111/apt.14597] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 191 |
Kim J, Kim K, Lee JS, Kim SY, Kim KO, Kim YJ, Kwon KA, Park DK, Chung JW. [The Efficacy of Rebamipide or Ecabet Sodium Supplementation for Helicobacter pylori Eradication Therapy Compared with Quadruple (Concomitant) Regimen]. Korean J Gastroenterol 2018;71:204-12. [PMID: 29684969 DOI: 10.4166/kjg.2018.71.4.204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 192 |
Zamani M, Ebrahimtabar F, Zamani V, Miller WH, Alizadeh-Navaei R, Shokri-Shirvani J, Derakhshan MH. Systematic review with meta-analysis: the worldwide prevalence of Helicobacter pylori infection. Aliment Pharmacol Ther 2018;47:868-76. [PMID: 29430669 DOI: 10.1111/apt.14561] [Cited by in Crossref: 361] [Cited by in F6Publishing: 368] [Article Influence: 72.2] [Reference Citation Analysis]
|
| 193 |
Sebghatollahi V, Soheilipour M, Khodadoostan M, Shavakhi A, Shavakhi A. Levofloxacin-containing versus Clarithromycin-containing Therapy for Helicobacter pylori Eradication: A Prospective Randomized Controlled Clinical Trial. Adv Biomed Res 2018;7:55. [PMID: 29657940 DOI: 10.4103/abr.abr_133_17] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 194 |
Chen J, Ye L, Jin L, Xu X, Xu P, Wang X, Li H. Application of next-generation sequencing to characterize novel mutations in clarithromycin-susceptible Helicobacter pylori strains with A2143G of 23S rRNA gene. Ann Clin Microbiol Antimicrob. 2018;17:10. [PMID: 29562911 DOI: 10.1186/s12941-018-0259-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 195 |
Pérez-arellano E, Rodriguez-garcia MI, Galera Rodenas AB, de la Morena-madrigal E. Eradication of Helicobacter pylori infection with a new bismuth-based quadruple therapy in clinical practice. Gastroenterología y Hepatología (English Edition) 2018;41:145-152. [DOI: 10.1016/j.gastre.2018.03.004] [Reference Citation Analysis]
|
| 196 |
Lee SM, Kim N, Kwon YH, Nam RH, Kim JM, Park JY, Lee YS, Lee DH. rdxA, frxA, and efflux pump in metronidazole-resistant Helicobacter pylori: Their relation to clinical outcomes. J Gastroenterol Hepatol 2018;33:681-8. [PMID: 28748532 DOI: 10.1111/jgh.13906] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 197 |
Calvet X. Dealing with uncertainty in the treatment of Helicobacter pylori. Ther Adv Chronic Dis 2018;9:93-102. [PMID: 29623181 DOI: 10.1177/2040622318758240] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 198 |
Zhou M, Liu J, Qi Y, Wang M, Wang Y, Zhao F, Hao Y, Zhao D. The association between Helicobacter pylori seropositivity and risk of new-onset diabetes: a prospective cohort study. Diabetologia 2018;61:300-7. [PMID: 29085991 DOI: 10.1007/s00125-017-4465-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 199 |
Chen ST, Ni YH, Liu SH. Potential Association of IL1B Polymorphism With Iron Deficiency Risk in Childhood Helicobacter pylori Infection. J Pediatr Gastroenterol Nutr 2018;66:e36-40. [PMID: 28727656 DOI: 10.1097/MPG.0000000000001687] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 200 |
Waller DG, Sampson AP. Dyspepsia and peptic ulcer disease. Medical Pharmacology and Therapeutics 2018. [DOI: 10.1016/b978-0-7020-7167-6.00033-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 201 |
Yeo YH, Shiu SI, Ho HJ, Zou B, Lin JT, Wu MS, Liou JM, Wu CY; Taiwan Gastrointestinal Disease and Helicobacter Consortium. First-line Helicobacter pylori eradication therapies in countries with high and low clarithromycin resistance: a systematic review and network meta-analysis. Gut 2018;67:20-7. [PMID: 27670375 DOI: 10.1136/gutjnl-2016-311868] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 10.6] [Reference Citation Analysis]
|
| 202 |
Lee MW, Kim GH, Han SY, Park YJ, Jeon HK, Lee BE, Song GA. First-lineHelicobacter pyloriEradication with Standard Triple Therapy and Concomitant Therapy: A Retrospective Study. Korean J Helicobacter Up Gastrointest Res 2018;18:120. [DOI: 10.7704/kjhugr.2018.18.2.120] [Reference Citation Analysis]
|
| 203 |
Sauberan JB, Bradley JS. Antimicrobial Agents. Principles and Practice of Pediatric Infectious Diseases 2018. [DOI: 10.1016/b978-0-323-40181-4.00292-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 204 |
Wanqun C, Ling H, Heyuan L, Qi L, Dongmei F, Yunzhan Z. Interleukin-12 and interferon-γ acting on damp-heat of spleen-stomach syndrome triggered by helicobacter pylori. Journal of Traditional Chinese Medicine 2017;37:827-34. [DOI: 10.1016/s0254-6272(18)30047-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 205 |
Ma L, Zeng J, Guo Q, Liang X, Shen L, Li S, Sun Y, Li W, Liu S, Yu H, Chen C, Jia J. Mutual amplification of HNF4α and IL-1R1 composes an inflammatory circuit in Helicobacter pylori associated gastric carcinogenesis. Oncotarget 2016;7:11349-63. [PMID: 26870992 DOI: 10.18632/oncotarget.7239] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 206 |
. Gastrointestinal Infections. Clinical Microbiology for Diagnostic Laboratory Scientists 2017. [DOI: 10.1002/9781118745847.ch4] [Reference Citation Analysis]
|
| 207 |
Dolan B, Burkitt-Gray L, Shovelin S, Bourke B, Drumm B, Rowland M, Clyne M. The use of stool specimens reveals Helicobacter pylori strain diversity in a cohort of adolescents and their family members in a developed country. Int J Med Microbiol 2018;308:247-55. [PMID: 29153619 DOI: 10.1016/j.ijmm.2017.11.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 208 |
Kim EH, Park CH. Vonoprazan-Based Helicobacter pylori Eradication Therapy: Time to Get Kompetitive? Dig Dis Sci 2017;62:2955-7. [PMID: 28776141 DOI: 10.1007/s10620-017-4699-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 209 |
Hu Y, Wan JH, Li XY, Zhu Y, Graham DY, Lu NH. Systematic review with meta-analysis: the global recurrence rate of Helicobacter pylori. Aliment Pharmacol Ther 2017;46:773-9. [PMID: 28892184 DOI: 10.1111/apt.14319] [Cited by in Crossref: 63] [Cited by in F6Publishing: 58] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 210 |
Ginestet F, Guibourg B, Doucet L, Théreaux J, Robaszkiewicz M, Marcorelles P, Uguen A. Upfront immunohistochemistry improves specificity of Helicobacter pylori diagnosis. A French pathology laboratory point of view. Helicobacter 2017;22. [PMID: 28799687 DOI: 10.1111/hel.12424] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 211 |
Zhang D, Ke L, Ni Z, Chen Y, Zhang LH, Zhu SH, Li CJ, Shang L, Liang J, Shi YQ. Berberine containing quadruple therapy for initial Helicobacter pylori eradication: An open-label randomized phase IV trial. Medicine (Baltimore) 2017;96:e7697. [PMID: 28796053 DOI: 10.1097/MD.0000000000007697] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 212 |
Jung YS, Park CH, Park JH, Nam E, Lee HL. Efficacy of Helicobacter pylori eradication therapies in Korea: A systematic review and network meta-analysis. Helicobacter 2017;22. [PMID: 28425141 DOI: 10.1111/hel.12389] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 213 |
Jung YS, Kim EH, Park CH. Systematic review with meta-analysis: the efficacy of vonoprazan-based triple therapy on Helicobacter pylori eradication. Aliment Pharmacol Ther 2017;46:106-14. [PMID: 28497487 DOI: 10.1111/apt.14130] [Cited by in Crossref: 85] [Cited by in F6Publishing: 71] [Article Influence: 14.2] [Reference Citation Analysis]
|
| 214 |
Lyseng-williamson KA. Pylera® (bismuth subcitrate potassium/metronidazole/tetracycline hydrochloride) in the eradication of Helicobacter pylori infection: a profile of its use in Europe. Drugs Ther Perspect 2017;33:311-320. [DOI: 10.1007/s40267-017-0417-7] [Reference Citation Analysis]
|
| 215 |
Perillo M, Becker-Weidman D, Bezuidenhout AF, Siewert B, Eisenberg RL. Infections of the Gastrointestinal Tract. Semin Roentgenol 2017;52:63-72. [PMID: 28606310 DOI: 10.1053/j.ro.2017.04.009] [Reference Citation Analysis]
|
| 216 |
Morilla A, Melón S, Álvarez-Argüelles ME, Armesto E, Villar H, de Oña M. Utility of normalized genome quantification of Helicobacter pylori in gastric mucosa using an in-house real-time polymerase chain reaction. PLoS One 2017;12:e0178674. [PMID: 28575047 DOI: 10.1371/journal.pone.0178674] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 217 |
Narang M, Puri AS, Sachdeva S, Singh J, Kumar A, Saran RK. Celiac disease and Helicobacter pylori infection in children: Is there any Association? J Gastroenterol Hepatol 2017;32:1178-82. [PMID: 27862319 DOI: 10.1111/jgh.13654] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 218 |
Chang YW, Oh CH, Kim JW, Lee JW, Park MJ, Shim JJ, Lee CK, Jang JY, Dong SH, Kim HJ, Kim SS, Kim BH. Combination of Helicobacter pylori infection and the interleukin 8 -251 T > A polymorphism, but not the mannose-binding lectin 2 codon 54 G > A polymorphism, might be a risk factor of gastric cancer. BMC Cancer. 2017;17:388. [PMID: 28558668 DOI: 10.1186/s12885-017-3378-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 219 |
Beckman E, Saracino I, Fiorini G, Clark C, Slepnev V, Patel D, Gomez C, Ponaka R, Elagin V, Vaira D. A Novel Stool PCR Test for Helicobacter pylori May Predict Clarithromycin Resistance and Eradication of Infection at a High Rate. J Clin Microbiol. 2017;55:2400-2405. [PMID: 28515219 DOI: 10.1128/jcm.00506-17] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 220 |
Hu Y, Zhu Y, Lu NH. Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance. Front Cell Infect Microbiol 2017;7:168. [PMID: 28529929 DOI: 10.3389/fcimb.2017.00168] [Cited by in Crossref: 68] [Cited by in F6Publishing: 75] [Article Influence: 11.3] [Reference Citation Analysis]
|
| 221 |
Omar H, Nordin N, Hassandarvish P, Hajrezaie M, Azizan AHS, Fadaeinasab M, Abdul Majid N, Abdulla MA, Mohd Hashim N, Mohd Ali H. Methanol leaf extract of Actinodaphne sesquipedalis (Lauraceae) enhances gastric defense against ethanol-induced ulcer in rats. Drug Des Devel Ther 2017;11:1353-65. [PMID: 28496305 DOI: 10.2147/DDDT.S120564] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 222 |
Eslami O, Shahraki M, Shahraki T, Ansari H. Association of Helicobacter pylori infection with metabolic parameters and dietary habits among medical undergraduate students in southeastern of Iran. J Res Med Sci 2017;22:12. [PMID: 28458704 DOI: 10.4103/1735-1995.199091] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 223 |
Smith S, Boyle B, Brennan D, Buckley M, Crotty P, Doyle M, Farrell R, Hussey M, Kevans D, Malfertheiner P, Megraud F, Nugent S, O'Connor A, O'Morain C, Weston S, McNamara D. The Irish Helicobacter pylori Working Group consensus for the diagnosis and treatment of H. pylori infection in adult patients in Ireland. Eur J Gastroenterol Hepatol 2017;29:552-9. [PMID: 28350745 DOI: 10.1097/MEG.0000000000000822] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 224 |
Harmati M, Gyukity-Sebestyen E, Dobra G, Terhes G, Urban E, Decsi G, Mimica-Dukić N, Lesjak M, Simin N, Pap B, Nemeth IB, Buzas K. Binary mixture of Satureja hortensis and Origanum vulgare subsp. hirtum essential oils: in vivo therapeutic efficiency against Helicobacter pylori infection. Helicobacter 2017;22. [PMID: 27578489 DOI: 10.1111/hel.12350] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 225 |
El-kady RAE, Department of Medical Microbiology and Immunology, Mansoura Faculty of Medicine, Mansoura, Egypt, Thaalab MM. Relevance between Helicobacter pylori Infection and Immune Thrombocytopenia. IJHT 2017;3:1-6. [DOI: 10.15436/2381-1404.17.018] [Reference Citation Analysis]
|
| 226 |
Park SM, Kim JS, Kim BW, Ji JS, Choi H. Randomized clinical trial comparing 10- or 14-day sequential therapy and 10- or 14-day concomitant therapy for the first line empirical treatment of Helicobacter pylori infection. J Gastroenterol Hepatol 2017;32:589-94. [PMID: 27505301 DOI: 10.1111/jgh.13510] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 227 |
Smith SM, Freeley M, Moynagh PN, Kelleher DP. Differential modulation of Helicobacter pylori lipopolysaccharide-mediated TLR2 signaling by individual Pellino proteins. Helicobacter 2017;22. [PMID: 27302665 DOI: 10.1111/hel.12325] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 228 |
Upala S, Sanguankeo A, Saleem SA, Jaruvongvanich V. Effects of Helicobacter pylori eradication on insulin resistance and metabolic parameters: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2017;29:153-9. [PMID: 27832037 DOI: 10.1097/MEG.0000000000000774] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 229 |
Kumar A. HELICOBACTER PYLORI INFECTION IN DYSPEPTIC PATIENTS IN INDUSTRIAL BELT IN JHARKHAND. jebmh 2017;4:445-448. [DOI: 10.18410/jebmh/2017/85] [Reference Citation Analysis]
|
| 230 |
Youn J, Kim SJ, Seo J, Kim J, Youn H, Ko JS, Kim KM, Chung J. National Survey Assessing Treatment of Helicobacter pylori Infection in Korean Children: A Pilot Study. Korean J Helicobacter Up Gastrointest Res 2017;17:195. [DOI: 10.7704/kjhugr.2017.17.4.195] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 231 |
Tsujimae M, Yamashita H, Hashimura H, Kano C, Shimoyama K, Kanamori A, Matsumoto K, Koizumi A, Momose K, Eguchi T, Fukuchi T, Fujita M, Okada A. A Comparative Study of a New Class of Gastric Acid Suppressant Agent Named Vonoparazan versus Esomeprazole for the Eradication of Helicobacter pylori. Digestion 2016;94:240-6. [PMID: 28030862 DOI: 10.1159/000454762] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 232 |
Park CH. The first-line regimens of Helicobacter pylori eradication in Korea. Hanyang Med Rev 2017;37:2. [DOI: 10.7599/hmr.2017.37.1.2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 233 |
George S, Mamani N, Lucero Y, Torres JP, Farfán M, Lagomarcino AJ, Orellana A, O'Ryan M. Detection of Helicobacter pylori by Real-Time PCR for 16s rRNA in Stools of NonInfected Healthy Children, Using ELISA Antigen Stool Test as the Gold Standard. Helicobacter 2016;21:606-12. [PMID: 27214853 DOI: 10.1111/hel.12318] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 234 |
Sawant P, Poddar P. Helicobacter pylori: past, present and future. Journal of Gastrointestinal Infections 2016;6:12-15. [DOI: 10.5005/jp-jogi-6-1-12] [Reference Citation Analysis]
|
| 235 |
Lecube A, Valladares S, López-Cano C, Gutiérrez L, Ciudin A, Fort JM, Reñé JM, Matias-Guiu X, de Torres I, Bueno M, Pallarés J, Baena JA. The Role of Morbid Obesity in the Promotion of Metabolic Disruptions and Non-Alcoholic Steatohepatitis by Helicobacter Pylori. PLoS One 2016;11:e0166741. [PMID: 27893763 DOI: 10.1371/journal.pone.0166741] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 236 |
Brennan DE, Omorogbe J, Hussey M, Tighe D, Holleran G, O’Morain C, Smith SM, McNamara D. Molecular detection of Helicobacter pylori antibiotic resistance in stool vs biopsy samples. World J Gastroenterol 2016; 22(41): 9214-9221 [PMID: 27895408 DOI: 10.3748/wjg.v22.i41.9214] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 237 |
Allison R, Lecky DM, Bull M, Turner K, Godbole G, McNulty CA. Audit of Helicobacter pylori Testing in Microbiology Laboratories in England: To Inform Compliance with NICE Guidance and the Feasibility of Routine Antimicrobial Resistance Surveillance. Int J Microbiol 2016;2016:8540904. [PMID: 27829836 DOI: 10.1155/2016/8540904] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 238 |
Wang YK, Kuo FC, Liu CJ, Wu MC, Shih HY, Wang SS, Wu JY, Kuo CH, Huang YK, Wu DC. Diagnosis of Helicobacter pylori infection: Current options and developments. World J Gastroenterol. 2015;21:11221-11235. [PMID: 26523098 DOI: 10.3748/wjg.v21.i40.11221.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 239 |
Hu Y, Liu JP, Zhu Y, Lu NH. The Importance of Toll-like Receptors in NF-κB Signaling Pathway Activation by Helicobacter pylori Infection and the Regulators of this Response. Helicobacter 2016;21:428-40. [PMID: 26763943 DOI: 10.1111/hel.12292] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 240 |
Murakami K, Sakurai Y, Shiino M, Funao N, Nishimura A, Asaka M. Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study. Gut 2016;65:1439-46. [PMID: 26935876 DOI: 10.1136/gutjnl-2015-311304] [Cited by in Crossref: 223] [Cited by in F6Publishing: 228] [Article Influence: 31.9] [Reference Citation Analysis]
|
| 241 |
Chen PY, Wu MS, Chen CY, Bair MJ, Chou CK, Lin JT, Liou JM; Taiwan Gastrointestinal Disease and Helicobacter Consortium. Systematic review with meta-analysis: the efficacy of levofloxacin triple therapy as the first- or second-line treatments of Helicobacter pylori infection. Aliment Pharmacol Ther 2016;44:427-37. [PMID: 27363687 DOI: 10.1111/apt.13712] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 7.1] [Reference Citation Analysis]
|
| 242 |
Kim BJ, Kim HS, Song HJ, Chung IK, Kim GH, Kim BW, Shim KN, Jeon SW, Jung YJ, Yang CH, Kim JH, Kim TH, Kim SG, Shin WG, Kim SM, Han SW, Lee JH, Kim KH, Park SK, Park BJ, Lee J, Kim JG; Korean College of Helicobacter and Upper Gastrointestinal Research. Online Registry for Nationwide Database of Current Trend of Helicobacter pylori Eradication in Korea: Interim Analysis. J Korean Med Sci 2016;31:1246-53. [PMID: 27478335 DOI: 10.3346/jkms.2016.31.8.1246] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 243 |
Lee JY, Kim N, Park KS, Kim HJ, Park SM, Baik GH, Shim KN, Oh JH, Choi SC, Kim SE, Kim WH, Park SY, Kim GH, Lee BE, Jo Y, Hong SJ. Comparison of sequential therapy and amoxicillin/tetracycline containing bismuth quadruple therapy for the first-line eradication of Helicobacter pylori: a prospective, multi-center, randomized clinical trial. BMC Gastroenterol. 2016;16:79. [PMID: 27460100 DOI: 10.1186/s12876-016-0490-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 244 |
Thevakumar K, Chandren JR, Perez-Perez GI, Chua EG, Teh LK, Salleh MZ, Tan JA, Leow AH, Goh KL, Tay AC, Marshall BJ, Vadivelu J, Loke MF, Wong LP. Assessment of Risk and Sero-Prevalence of Helicobacter pylori Colonization among Remote Orang Asli Tribes in Peninsula Malaysia. PLoS One 2016;11:e0159830. [PMID: 27441568 DOI: 10.1371/journal.pone.0159830] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 245 |
Upala S, Jaruvongvanich V, Riangwiwat T, Jaruvongvanich S, Sanguankeo A. Association between Helicobacter pylori infection and metabolic syndrome: a systematic review and meta-analysis. J Dig Dis 2016;17:433-40. [PMID: 27273478 DOI: 10.1111/1751-2980.12367] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 246 |
Fallone CA, Chiba N, van Zanten SV, Fischbach L, Gisbert JP, Hunt RH, Jones NL, Render C, Leontiadis GI, Moayyedi P, Marshall JK. The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults. Gastroenterology 2016;151:51-69.e14. [PMID: 27102658 DOI: 10.1053/j.gastro.2016.04.006] [Cited by in Crossref: 510] [Cited by in F6Publishing: 527] [Article Influence: 72.9] [Reference Citation Analysis]
|
| 247 |
Puig I, López-Góngora S, Calvet X, Villoria A, Baylina M, Sanchez-Delgado J, Suarez D, García-Hernando V, Gisbert JP. Systematic review: third-line susceptibility-guided treatment for Helicobacter pylori infection. Therap Adv Gastroenterol 2016;9:437-48. [PMID: 27366212 DOI: 10.1177/1756283X15621229] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 248 |
Yang W, Xuan C. Influence of Helicobacter pylori Infection on Metabolic Syndrome in Old Chinese People. Gastroenterol Res Pract 2016;2016:6951264. [PMID: 27429613 DOI: 10.1155/2016/6951264] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 249 |
Shafaghi A, Pourkazemi A, Khosravani M, Fakhrie Asl S, Amir Maafi A, Atrkar Roshan Z, Abaspour Rahimabad J. The Effect of Probiotic Plus Prebiotic Supplementation on the Tolerance and Efficacy of Helicobacter Pylori Eradication Quadruple Therapy: a Randomized Prospective Double Blind Controlled Trial. Middle East J Dig Dis 2016;8:179-88. [PMID: 27698967 DOI: 10.15171/mejdd.2016.30] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 250 |
Abd-Elsalam S, Kobtan A, El-Kalla F, Elkhalawany W, Nawasany SE, Saif SA, Yousef M, Ali LA, Soliman S, Mansour L, Habba E, Soliman H, Rizk F, Shehata MA. A 2-week Nitazoxanide-based quadruple treatment as a rescue therapy for Helicobacter pylori eradication: A single center experience. Medicine (Baltimore) 2016;95:e3879. [PMID: 27310977 DOI: 10.1097/MD.0000000000003879] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 251 |
Quek C, Pham ST, Tran KT, Pham BT, Huynh LV, Luu NB, Le TK, Quek K, Pham VH. Antimicrobial susceptibility and clarithromycin resistance patterns of Helicobacter pylori clinical isolates in Vietnam. F1000Res 2016;5:671. [PMID: 27583131 DOI: 10.12688/f1000research.8239.1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 252 |
Liu X, He B, Cho WC, Pan Y, Chen J, Ying H, Wang F, Lin K, Peng H, Wang S. A systematic review on the association between the Helicobacter pylori vacA i genotype and gastric disease. FEBS Open Bio. 2016;6:409-417. [PMID: 27419046 DOI: 10.1002/2211-5463.12046] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 253 |
Bartels LE, Jepsen P, Christensen LA, Gerdes LU, Vilstrup H, Dahlerup JF. Diagnosis of Helicobacter Pylori Infection is Associated with Lower Prevalence and Subsequent Incidence of Crohn's Disease. J Crohns Colitis 2016;10:443-8. [PMID: 26674958 DOI: 10.1093/ecco-jcc/jjv229] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 254 |
Magen E, Waitman DA, Goldstein N, Schlesinger M, Dickstein Y, Kahan NR. Helicobacter pylori infection in patients with selective immunoglobulin a deficiency. Clin Exp Immunol 2016;184:332-7. [PMID: 26749258 DOI: 10.1111/cei.12765] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 255 |
Lee JY, Kim N, Choi YJ, Nam RH, Lee S, Ham MH, Suh JH, Choi YJ, Lee HS, Lee DH. Anti-inflammatory and Anti-tumorigenic Effects of Açai Berry in Helicobacter felis-infected mice. J Cancer Prev 2016;21:48-54. [PMID: 27051649 DOI: 10.15430/JCP.2016.21.1.48] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 256 |
Hakemi Vala M, Eyvazi S, Goudarzi H, Sarie HR, Gholami M. Evaluation of Clarithromycin Resistance Among Iranian Helicobacter pylori Isolates by E-Test and Real-Time Polymerase Chain Reaction Methods. Jundishapur J Microbiol 2016;9:e29839. [PMID: 27540451 DOI: 10.5812/jjm.29839] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 257 |
Kefeli A, Başyigit S, Yeniova AO, Ozkan S, Nazligul Y. Comparison of the efficacy and safety of hybrid and sequential therapies as a first-line regimen for Helicobacter pylori infection in Turkey. Arch Med Sci 2018;14:276-80. [PMID: 29593799 DOI: 10.5114/aoms.2016.58595] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 258 |
Lee ST, Lee DH, Lim JH, Kim N, Park YS, Shin CM, Jo HJ, Song IS. Efficacy of 7-Day and 14-Day Bismuth-Containing Quadruple Therapy and 7-Day and 14-Day Moxifloxacin-Based Triple Therapy as Second-Line Eradication for Helicobacter pylori Infection. Gut Liver. 2015;9:478-485. [PMID: 25071068 DOI: 10.5009/gnl14020] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 259 |
Chang YW, Jang JY, Kim YH, Kim JW, Shim JJ. The Effects of Broccoli Sprout Extract Containing Sulforaphane on Lipid Peroxidation and Helicobacter pylori Infection in the Gastric Mucosa. Gut Liver 2015;9:486-93. [PMID: 25287166 DOI: 10.5009/gnl14040] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 260 |
Khalil MA, El-Sheekh MM, El-Adawi HI, El-Deeb NM, Hussein MZ. Efficacy of microencapsulated lactic acid bacteria in Helicobater pylori eradication therapy. J Res Med Sci. 2015;20:950-957. [PMID: 26929759 DOI: 10.4103/1735-1995.172782] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 261 |
Di Giulio M, Di Campli E, Di Bartolomeo S, Cataldi V, Marzio L, Grossi L, Ciccaglione AF, Nostro A, Cellini L. In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy. Scand J Gastroenterol 2016;51:263-9. [PMID: 26554617 DOI: 10.3109/00365521.2015.1092577] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 262 |
Seo JH, Lim CW, Park JS, Yeom JS, Lim JY, Jun JS, Woo HO, Youn HS, Baik SC, Lee WK, Cho MJ, Rhee KH. Correlations between the CagA Antigen and Serum Levels of Anti-Helicobacter pylori IgG and IgA in Children. J Korean Med Sci 2016;31:417-22. [PMID: 26955243 DOI: 10.3346/jkms.2016.31.3.417] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 263 |
Çamcı G, Oğuz S. Association between Parkinson's Disease and Helicobacter Pylori. J Clin Neurol 2016;12:147-50. [PMID: 26932258 DOI: 10.3988/jcn.2016.12.2.147] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 8.6] [Reference Citation Analysis]
|
| 264 |
Jonaitis L, Kiudelis G, Slepavicius P, Kupcinskas L. High rate of Helicobacter pylori reinfection in Lithuanian peptic ulcer patients. World J Gastrointest Pathophysiol 2016; 7(1): 181-185 [PMID: 26909241 DOI: 10.4291/wjgp.v7.i1.181] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 265 |
Thung I, Aramin H, Vavinskaya V, Gupta S, Park JY, Crowe SE, Valasek MA. Review article: the global emergence of Helicobacter pylori antibiotic resistance. Aliment Pharmacol Ther 2016;43:514-33. [PMID: 26694080 DOI: 10.1111/apt.13497] [Cited by in Crossref: 410] [Cited by in F6Publishing: 381] [Article Influence: 58.6] [Reference Citation Analysis]
|
| 266 |
Lee HS. Histopathologic Diagnosis of H. pylori Infection and Associated Gastric Diseases. Helicobacter pylori 2016. [DOI: 10.1007/978-981-287-706-2_9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 267 |
Nguewa PA, Villa TG, Notario V. Microbiome Control in the Prevention and Early Management of Cancer. New Weapons to Control Bacterial Growth 2016. [DOI: 10.1007/978-3-319-28368-5_10] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 268 |
Burd EM, Hinrichs BH. Gastrointestinal Infections. Molecular Pathology in Clinical Practice 2016. [DOI: 10.1007/978-3-319-19674-9_50] [Reference Citation Analysis]
|
| 269 |
Offermanns S. Pharmaka mit Wirkung auf die Magenfunktion. Pharmakologie und Toxikologie 2016. [DOI: 10.1007/978-3-662-46689-6_45] [Reference Citation Analysis]
|
| 270 |
Chen Y, Lu Y, Aldahab H, Barkun A. Approach to Suspected Nonvariceal Upper Gastrointestinal Bleeding. GI Endoscopic Emergencies 2016. [DOI: 10.1007/978-1-4939-3085-2_3] [Reference Citation Analysis]
|
| 271 |
Kefeli A, Basyigit S, Yeniova AO, Kefeli TT, Aslan M, Tanas O. Comparison of three different regimens against Helicobacter pylori as a first-line treatment: A randomized clinical trial. Bosn J Basic Med Sci 2016;16:52-7. [PMID: 26773183 DOI: 10.17305/bjbms.2016.660] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 272 |
Li H, Zhou Y, Zheng Y, Guo H, Gao L, Chen P, Feng D, Wu L, Yang M, Qi Y, Guo H, Chang Y, Chu FF, Gao Q. The Gastric Mucosa from Patients Infected with CagA+ or VacA+ Helicobacter pylori Has a Lower Level of Dual Oxidase-2 Expression than Uninfected or Infected with CagA-/VacA- H. pylori. Dig Dis Sci 2016;61:2328-37. [PMID: 27048452 DOI: 10.1007/s10620-016-4144-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 273 |
The Gastrointestinal Microbiome. Molecular Microbiology 2016. [DOI: 10.1128/9781555819071.ch11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 274 |
Kaur B, Kaur G. Amelioration of Helicobacter pylori-Induced PUD by Probiotic Lactic Acid Bacteria. Probiotics, Prebiotics, and Synbiotics 2016. [DOI: 10.1016/b978-0-12-802189-7.00067-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 275 |
Strasfeld L, Dummer S. Other Bacterial Infections After Hematopoietic Stem Cell or Solid Organ Transplantation. Transplant Infections 2016. [DOI: 10.1007/978-3-319-28797-3_23] [Reference Citation Analysis]
|
| 276 |
Jung SM, Cheung DY, Kim JI, Kim I, Seong H. Comparing the Efficacy of Concomitant Therapy with Sequential Therapy as the First-Line Therapy of Helicobacter pylori Eradication. Gastroenterol Res Pract 2016;2016:1293649. [PMID: 26823662 DOI: 10.1155/2016/1293649] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 277 |
Gram-negative rods. Practical Medical Microbiology for Clinicians 2015. [DOI: 10.1002/9781119066767.ch13] [Reference Citation Analysis]
|
| 278 |
Smith SM. An Update on the Treatment of Helicobacter Pylori Infection. EMJ Gastroenterol 2015. [DOI: 10.33590/emjgastroenterol/10310813] [Reference Citation Analysis]
|
| 279 |
Lim JH, Lee DH, Lee ST, Kim N, Park YS, Shin CM, Song IS. Moxifloxacin-containing triple therapy after non-bismuth quadruple therapy failure for Helicobacter pylori infection. World J Gastroenterol 2015; 21(46): 13124-13131 [PMID: 26673999 DOI: 10.3748/wjg.v21.i46.13124] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 280 |
Seo SI, Kim SJ, Kim HS, Shin WG, Kim KH, Jang MK, Lee JH, Kim HY. Is There Any Difference in the Eradication Rate of Helicobacter pylori Infection According to the Endoscopic Stage of Peptic Ulcer Disease? Helicobacter 2015;20:424-30. [PMID: 25752487 DOI: 10.1111/hel.12221] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 281 |
Ingram RJ, Ragunath K, Atherton JC. Peptic Ulcer Disease. Yamada' s Textbook of Gastroenterology 2015. [DOI: 10.1002/9781118512074.ch56] [Reference Citation Analysis]
|
| 282 |
Kim SY, Choi DJ, Chung JW. Antibiotic treatment for Helicobacter pylori: Is the end coming? World J Gastrointest Pharmacol Ther 2015; 6(4): 183-198 [PMID: 26558152 DOI: 10.4292/wjgpt.v6.i4.183] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 54] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 283 |
Chang SS, Hu HY. Helicobacter pylori: Effect of coexisting diseases and update on treatment regimens. World J Gastrointest Pharmacol Ther 2015; 6(4): 127-136 [PMID: 26558147 DOI: 10.4292/wjgpt.v6.i4.127] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 284 |
Bang CS, Baik GH. Time to learn from the past and prepare for the future in Helicobacter pylori eradication. Korean J Intern Med 2015;30:789-91. [PMID: 26552453 DOI: 10.3904/kjim.2015.30.6.789] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 285 |
Wang YK, Kuo FC, Liu CJ, Wu MC, Shih HY, Wang SS, Wu JY, Kuo CH, Huang YK, Wu DC. Diagnosis of Helicobacter pylori infection: Current options and developments. World J Gastroenterol 2015; 21(40): 11221-11235 [PMID: 26523098 DOI: 10.3748/wjg.v21.i40.11221] [Cited by in CrossRef: 192] [Cited by in F6Publishing: 210] [Article Influence: 24.0] [Reference Citation Analysis]
|
| 286 |
Yang L, Hao WW, Li Y, Xu F. Efficacy of different courses of concomitant therapy and bismuth containing quadruple therapy for eradication of Helicobacter pylori. Shijie Huaren Xiaohua Zazhi 2015; 23(28): 4589-4594 [DOI: 10.11569/wcjd.v23.i28.4589] [Reference Citation Analysis]
|
| 287 |
Weiner N, Shaoul R. Impact of Age, Gender, and Addition of Probiotics on Treatment Success for Helicobacter pylori in Children. Glob Pediatr Health 2015;2:2333794X15607798. [PMID: 27335981 DOI: 10.1177/2333794X15607798] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 288 |
Rakici H, Ayaz T, Akdogan RA, Bedir R. Comparison of levofloxacin- and moxifloxacin-based triple therapies with standard treatment in eradication of Helicobacter pylori as first-line therapy. Digestion 2014;90:261-4. [PMID: 25547786 DOI: 10.1159/000369788] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 289 |
Yari F, Abiri R, Aryan E, Ahmadi Jouybari T, Navabi J, Alvandi A. Loop-Mediated Isothermal Amplification as a Fast Noninvasive Method of Helicobacter pylori Diagnosis. J Clin Lab Anal 2016;30:464-70. [PMID: 26351213 DOI: 10.1002/jcla.21880] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 290 |
Li BZ, Threapleton DE, Wang JY, Xu JM, Yuan JQ, Zhang C, Li P, Ye QL, Guo B, Mao C, Ye DQ. Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis. BMJ 2015;351:h4052. [PMID: 26290044 DOI: 10.1136/bmj.h4052] [Cited by in Crossref: 104] [Cited by in F6Publishing: 103] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 291 |
Eng NF, Ybazeta G, Chapman K, Fraleigh NL, Letto R, Altman E, Diaz-Mitoma F. Antimicrobial susceptibility of Canadian isolates of Helicobacter pylori in Northeastern Ontario. Can J Infect Dis Med Microbiol 2015;26:137-44. [PMID: 26236355 DOI: 10.1155/2015/853287] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 292 |
Bang CS, Baik GH. <i>Helicobacter Pylori</i> Infection and Related Gastrointestinal Diseases. Korean J Med 2015;89:142-148. [DOI: 10.3904/kjm.2015.89.2.142] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 293 |
Kim BJ, Kim JG. Epidemiology and Pathophysiology of <i>Helicobacter Pylori</i> Infections in Korea. Korean J Med 2015;89:133-41. [DOI: 10.3904/kjm.2015.89.2.133] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 294 |
Ermis F, Tasci ES. Current Helicobacter pylori treatment in 2014. World J Methodol 2015; 5(2): 101-107 [PMID: 26140276 DOI: 10.5662/wjm.v5.i2.101] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 295 |
Vellozzi E, Giugliano E. The Genus Helicobacter. Practical Handbook of Microbiology, Third Edition 2015. [DOI: 10.1201/b17871-42] [Reference Citation Analysis]
|
| 296 |
Shady MM, Fathy HA, Ali A, Galal EM, Fathy GA, Sibaii H. Comparison of Serum IgG Antibody Test with Gastric Biopsy for the Detection of Helicobacter Pylori Infection among Egyptian Children. Open Access Maced J Med Sci. 2015;3:303-306. [PMID: 27275240 DOI: 10.3889/oamjms.2015.062] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 297 |
Montes M, Villalon FN, Eizaguirre FJ, Delgado M, Muñoz-Seca IM, Fernández-Reyes M, Pérez-Trallero E. Helicobacter pylori Infection in Children. Antimicrobial Resistance and Treatment Response. Helicobacter 2015;20:169-75. [PMID: 25382231 DOI: 10.1111/hel.12187] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 298 |
Chen TP, Hung HF, Chen MK, Lai HH, Hsu WF, Huang KC, Yang KC. Helicobacter Pylori Infection is Positively Associated with Metabolic Syndrome in Taiwanese Adults: a Cross-Sectional Study. Helicobacter 2015;20:184-91. [PMID: 25582223 DOI: 10.1111/hel.12190] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 299 |
Jheng GH, Wu IC, Shih HY, Wu MC, Kuo FC, Hu HM, Liu CJ, Hsu WH, Hu CT, Bair MJ, Kuo CH, Wu DC, Hsu PI. Comparison of Second-Line Quadruple Therapies with or without Bismuth for Helicobacter pylori Infection. Biomed Res Int 2015;2015:163960. [PMID: 26090383 DOI: 10.1155/2015/163960] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 300 |
Yang JC, Lin CJ, Wang HL, Chen JD, Kao JY, Shun CT, Lu CW, Lin BR, Shieh MJ, Chang MC, Chang YT, Wei SC, Lin LC, Yeh WC, Kuo JS, Tung CC, Leong YL, Wang TH, Wong JM. High-dose dual therapy is superior to standard first-line or rescue therapy for Helicobacter pylori infection. Clin Gastroenterol Hepatol 2015;13:895-905.e5. [PMID: 25460556 DOI: 10.1016/j.cgh.2014.10.036] [Cited by in Crossref: 114] [Cited by in F6Publishing: 123] [Article Influence: 14.3] [Reference Citation Analysis]
|
| 301 |
Hwang JJ, Lee DH, Lee AR, Yoon H, Shin CM, Park YS, Kim N. Characteristics of gastric cancer in peptic ulcer patients with Helicobacter pylori infection. World J Gastroenterol 2015; 21(16): 4954-4960 [PMID: 25945009 DOI: 10.3748/wjg.v21.i16.4954] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 302 |
Peretz A, Paritsky M, Pastukh N, Koifman A, Brodsky D, Glyatman T, On A. Improvement and optimization of the classical gastric biopsy culture technique for Helicobacter pylori diagnosis using trypsin. J Med Microbiol 2015;64:642-5. [PMID: 25878170 DOI: 10.1099/jmm.0.000054] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 303 |
Zhang MM, Qian W, Qin YY, He J, Zhou YH. Probiotics in Helicobacter pylori eradication therapy: A systematic review and meta-analysis. World J Gastroenterol 2015; 21(14): 4345-4357 [PMID: 25892886 DOI: 10.3748/wjg.v21.i14.4345] [Cited by in CrossRef: 101] [Cited by in F6Publishing: 102] [Article Influence: 12.6] [Reference Citation Analysis]
|
| 304 |
Wang B, Wang YH, Lv ZF, Xiong HF, Wang H, Yang Y, Xie Y. Review: efficacy and safety of hybrid therapy for Helicobacter pylori infection: a systematic review and meta-analysis. Helicobacter 2015;20:79-88. [PMID: 25381839 DOI: 10.1111/hel.12180] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 305 |
Kumar A, Shah BJ. Medical evaluation for patients with symptomatic esophageal disease. Techniques in Gastrointestinal Endoscopy 2015;17:48-52. [DOI: 10.1016/j.tgie.2015.03.004] [Reference Citation Analysis]
|
| 306 |
Yap TW, Chan WK, Leow AH, Azmi AN, Loke MF, Vadivelu J, Goh KL. Prevalence of serum celiac antibodies in a multiracial Asian population--a first study in the young Asian adult population of Malaysia. PLoS One. 2015;10:e0121908. [PMID: 25799401 DOI: 10.1371/journal.pone.0121908] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 307 |
Allahverdiyev AM, Bagirova M, Caliskan R, Tokman HB, Aliyeva H, Unal G, Oztel ON, Abamor ES, Toptas H, Yuksel P, Kalayci F, Aslan M, Erzin Y, Bal K, Kocazeybek BS. Isolation and diagnosis of Helicobacter pylori by a new method: Microcapillary culture. World J Gastroenterol 2015; 21(9): 2622-2628 [PMID: 25759529 DOI: 10.3748/wjg.v21.i9.2622] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 308 |
Ghosh P, Bodhankar SL. Association of smoking, alcohol and NSAIDs use with expression of cag A and cag T genes of Helicobacter pylori in salivary samples of asymptomatic subjects. Asian Pac J Trop Biomed 2012;2:479-84. [PMID: 23569954 DOI: 10.1016/S2221-1691(12)60080-X] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 309 |
Schulz C, Koch N, Schütte K, Pieper DH, Malfertheiner P. H. pylori and its modulation of gastrointestinal microbiota. J Dig Dis 2015;16:109-17. [PMID: 25624012 DOI: 10.1111/1751-2980.12233] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 310 |
Yoon K, Kim N, Nam RH, Suh JH, Lee S, Kim JM, Lee JY, Kwon YH, Choi YJ, Yoon H, Shin CM, Park YS, Lee DH. Ultimate eradication rate of Helicobacter pylori after first, second, or third-line therapy in Korea. J Gastroenterol Hepatol 2015;30:490-5. [PMID: 25363555 DOI: 10.1111/jgh.12839] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 311 |
Lv ZF, Wang FC, Zheng HL, Wang B, Xie Y, Zhou XJ, Lv NH. Meta-analysis: Is combination of tetracycline and amoxicillin suitable for Helicobacter pylori infection? World J Gastroenterol 2015; 21(8): 2522-2533 [PMID: 25741163 DOI: 10.3748/wjg.v21.i8.2522] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 312 |
Lee JY, Kim N. Diagnosis of Helicobacter pylori by invasive test: histology. Ann Transl Med. 2015;3:10. [PMID: 25705642 DOI: 10.3978/j.issn.2305-5839.2014.11.03] [Cited by in F6Publishing: 38] [Reference Citation Analysis]
|
| 313 |
Wang F, Wu X, Liu Z, Bu G, Li X, Qu N, Peng J, Xu C, Shen S, Yuan Y. Association between Virulence Factors and TRAF1/4-1BB/Bcl-xL Expression in Gastric Mucosa Infected with Helicobacter pylori. Gastroenterol Res Pract. 2015;2015:648479. [PMID: 25737718 DOI: 10.1155/2015/648479] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 314 |
Binh TT, Suzuki R, Trang TT, Kwon DH, Yamaoka Y. Search for novel candidate mutations for metronidazole resistance in Helicobacter pylori using next-generation sequencing. Antimicrob Agents Chemother. 2015;59:2343-2348. [PMID: 25645832 DOI: 10.1128/aac.04852-14] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 315 |
Sato Y, Yoneyama O, Azumaya M, Takeuchi M, Sasaki SY, Yokoyama J, Shioji K, Kawauchi Y, Hashimoto S, Nishigaki Y, Kobayashi M, Sugimura K, Honma T, Narisawa R, Aoyagi Y. The relationship between iron deficiency in patients with Helicobacter pylori-infected nodular gastritis and the serum prohepcidin level. Helicobacter 2015;20:11-8. [PMID: 25256783 DOI: 10.1111/hel.12170] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 316 |
Ferwana M, Abdulmajeed I, Alhajiahmed A, Madani W, Firwana B, Hasan R, Altayar O, Limburg PJ, Murad MH, Knawy B. Accuracy of urea breath test in Helicobacter pylori infection: Meta-analysis. World J Gastroenterol 2015; 21(4): 1305-1314 [PMID: 25632206 DOI: 10.3748/wjg.v21.i4.1305] [Cited by in CrossRef: 118] [Cited by in F6Publishing: 125] [Article Influence: 14.8] [Reference Citation Analysis]
|
| 317 |
Lee HJ, Kim JI, Lee JS, Jun EJ, Oh JH, Cheung DY, Chung WC, Kim BW, Kim SS. Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies. World J Gastroenterol 2015; 21(1): 351-359 [PMID: 25574111 DOI: 10.3748/wjg.v21.i1.351] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 55] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 318 |
Chapter 25. Gastrointestinal Diseases. The APhA Complete Review for Pharmacy, 11th Edition 2015. [DOI: 10.21019/9781582122175.ch25] [Reference Citation Analysis]
|
| 319 |
Atzeni F, Benucci M, Batticciotto A, Sarzi-puttini P. Helicobacter pylori Infection and Gastric Autoimmunity. Infection and Autoimmunity 2015. [DOI: 10.1016/b978-0-444-63269-2.00070-2] [Reference Citation Analysis]
|
| 320 |
Chang SS, Hu HY. Association between early Helicobacter pylori eradication and a lower risk of recurrent complicated peptic ulcers in end-stage renal disease patients. Medicine (Baltimore) 2015;94:e370. [PMID: 25569660 DOI: 10.1097/MD.0000000000000370] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 321 |
Nagel JL, Aronoff DM. Metronidazole. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases 2015. [DOI: 10.1016/b978-1-4557-4801-3.00028-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 322 |
Tadjrobehkar O, Abdollahi H. A Novel Reduction Strategy of Clarithromycin Resistance in Helicobacter pylori. Jundishapur J Microbiol. 2014;7:e13081. [PMID: 25741431 DOI: 10.5812/jjm.13081] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 323 |
Wisessombat S, Meethai C. Prevalence of Helicobacter pylori cagA genotype among dyspeptic patients in Southern Thailand. Asian Pacific Journal of Reproduction 2014;3:317-319. [DOI: 10.1016/s2305-0500(14)60046-4] [Reference Citation Analysis]
|
| 324 |
Thamphiwatana S, Gao W, Obonyo M, Zhang L. In vivo treatment of Helicobacter pylori infection with liposomal linolenic acid reduces colonization and ameliorates inflammation. Proc Natl Acad Sci U S A. 2014;111:17600-17605. [PMID: 25422427 DOI: 10.1073/pnas.1418230111] [Cited by in Crossref: 77] [Cited by in F6Publishing: 82] [Article Influence: 8.6] [Reference Citation Analysis]
|
| 325 |
Rodrigo L, Blanco I, Bobes J, de Serres FJ. Remarkable prevalence of coeliac disease in patients with irritable bowel syndrome plus fibromyalgia in comparison with those with isolated irritable bowel syndrome: a case-finding study. Arthritis Res Ther 2013;15:R201. [PMID: 24283458 DOI: 10.1186/ar4391] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 326 |
Del Piano M, Pagliarulo M, Tari R, Carmagnola S, Balzarini M, Lorenzini P, Pane M. Correlation between chronic treatment with proton pump inhibitors and bacterial overgrowth in the stomach: any possible beneficial role for selected lactobacilli? J Clin Gastroenterol 2014;48 Suppl 1:S40-6. [PMID: 25291126 DOI: 10.1097/MCG.0000000000000256] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 327 |
McLean MH, El-Omar EM. Genetics of gastric cancer. Nat Rev Gastroenterol Hepatol 2014;11:664-74. [PMID: 25134511 DOI: 10.1038/nrgastro.2014.143] [Cited by in Crossref: 250] [Cited by in F6Publishing: 271] [Article Influence: 27.8] [Reference Citation Analysis]
|
| 328 |
Marín AC, Mcnicholl AG, Savarino V, Calvet X, Leontiadis GI, Fischbach L, Yuan Y, Gisbert JP; Cochrane Upper GI and Pancreatic Diseases Group. Optimum second-line regimens for Helicobacter pylori eradication. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd011363] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 329 |
Wang B, Lv ZF, Wang YH, Wang H, Liu XQ, Xie Y, Zhou XJ. Standard triple therapy for Helicobacter pylori infection in China: A meta-analysis. World J Gastroenterol 2014; 20(40): 14973-14985 [PMID: 25356059 DOI: 10.3748/wjg.v20.i40.14973] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 35] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 330 |
Lee JY, Kim N, Nam RH, Choi YJ, Seo JH, Lee HS, Oh JC, Lee DH. No Correlation of Inflammation With Colonization of Helicobacter pylori in the Stomach of Mice Fed High-salt Diet. J Cancer Prev. 2014;19:144-151. [PMID: 25337583 DOI: 10.15430/jcp.2014.19.2.144] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 331 |
Lee JY, Kim N, Choi YJ, Nam RH, Choi YJ, Kwon YH, Yoon K, Suh JH, Lee SM, Lee HS, Lee DH. Histologic Findings and Inflammatory Reactions After Long-term Colonization of Helicobacter felis in C57BL/6 Mice. J Cancer Prev 2014;19:224-30. [PMID: 25337592 DOI: 10.15430/JCP.2014.19.3.224] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 332 |
Doğan Z, Özdemir P, Ekşioğlu M, Filik L. Relationship between Helicobacter pylori infection and vitiligo: a prospective study. Am J Clin Dermatol 2014;15:457-62. [PMID: 24985165 DOI: 10.1007/s40257-014-0087-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 333 |
Wang Y, Wang B, Lv ZF, Yang Y, Wang F, Wang H, Chen S, Xie Y, Zhou X. Efficacy and safety of ecabet sodium as an adjuvant therapy for Helicobacter pylori eradication: a systematic review and meta-analysis. Helicobacter 2014;19:372-81. [PMID: 24826809 DOI: 10.1111/hel.12136] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 334 |
Schulz TR, McBryde ES, Leder K, Biggs BA. Using stool antigen to screen for Helicobacter pylori in immigrants and refugees from high prevalence countries is relatively cost effective in reducing the burden of gastric cancer and peptic ulceration. PLoS One 2014;9:e108610. [PMID: 25268809 DOI: 10.1371/journal.pone.0108610] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 335 |
Patel SK, Pratap CB, Jain AK, Gulati AK, Nath G. Diagnosis of Helicobacter pylori: What should be the gold standard? World J Gastroenterol 2014; 20(36): 12847-12859 [PMID: 25278682 DOI: 10.3748/wjg.v20.i36.12847] [Cited by in CrossRef: 140] [Cited by in F6Publishing: 153] [Article Influence: 15.6] [Reference Citation Analysis]
|
| 336 |
Zhang S, Lee DS, Morrissey R, Aponte-Pieras JR, Rogers AB, Moss SF. Early or late antibiotic intervention prevents Helicobacter pylori-induced gastric cancer in a mouse model. Cancer Lett 2014;355:106-12. [PMID: 25218349 DOI: 10.1016/j.canlet.2014.09.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 337 |
Lee JW, Kim N, Nam RH, Park JH, Choi YJ, Kim JM, Kim JS, Jung HC. GenoType HelicoDR test in the determination of antimicrobial resistance of Helicobacter pylori in Korea. Scand J Gastroenterol 2014;49:1058-67. [PMID: 24957849 DOI: 10.3109/00365521.2014.894117] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 338 |
Rakici H, Akdoğan RA, Bedir R, Copur A, Yilmaz A. Comparison of standard triple therapy, sequential therapy and moxifloxacin-based triple therapy for Helicobacter pylori infection: Patients' compliance and bacterial eradication rates. J Dig Dis 2014;15:508-13. [PMID: 24980811 DOI: 10.1111/1751-2980.12171] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 339 |
Rodrigo L, Blanco I, Bobes J, de Serres FJ. Effect of one year of a gluten-free diet on the clinical evolution of irritable bowel syndrome plus fibromyalgia in patients with associated lymphocytic enteritis: a case-control study. Arthritis Res Ther 2014;16:421. [PMID: 25160886 DOI: 10.1186/s13075-014-0421-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 340 |
Rollan A, Arab JP, Camargo MC, Candia R, Harris P, Ferreccio C, Rabkin CS, Gana JC, Cortés P, Herrero R, Durán L, García A, Toledo C, Espino A, Lustig N, Sarfatis A, Figueroa C, Torres J, Riquelme A. Management of Helicobacter pylori infection in Latin America: A Delphi technique-based consensus. World J Gastroenterol 2014; 20(31): 10969-10983 [PMID: 25152601 DOI: 10.3748/wjg.v20.i31.10969] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 341 |
Smith SM. Role of Toll-like receptors in Helicobacter pylori infection and immunity. World J Gastrointest Pathophysiol 2014; 5(3): 133-146 [PMID: 25133016 DOI: 10.4291/wjgp.v5.i3.133] [Cited by in CrossRef: 61] [Cited by in F6Publishing: 68] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 342 |
Kuo FC, Wu CY, Kuo CH, Wu CF, Lu CY, Chen YH, Chen CY, Lo YC, Wu MT, Hu HM. The utilization of a new immunochromatographic test in detection of Helicobacter pylori antibody from maternal and umbilical cord serum. Biomed Res Int 2014;2014:568410. [PMID: 25177695 DOI: 10.1155/2014/568410] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 343 |
Smith SM, O’Morain C, McNamara D. Antimicrobial susceptibility testing for Helicobacter pylori in times of increasing antibiotic resistance. World J Gastroenterol 2014; 20(29): 9912-9921 [PMID: 25110421 DOI: 10.3748/wjg.v20.i29.9912] [Cited by in CrossRef: 91] [Cited by in F6Publishing: 96] [Article Influence: 10.1] [Reference Citation Analysis]
|
| 344 |
Adler I, Muiño A, Aguas S, Harada L, Diaz M, Lence A, Labbrozzi M, Muiño JM, Elsner B, Avagnina A, Denninghoff V. Helicobacter pylori and oral pathology: Relationship with the gastric infection. World J Gastroenterol 2014; 20(29): 9922-9935 [PMID: 25110422 DOI: 10.3748/wjg.v20.i29.9922] [Cited by in CrossRef: 57] [Cited by in F6Publishing: 61] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 345 |
Chang SS, Hu HY. H. pylori eradication lower ulcers in cirrhosis. [Corrected]. J Dig Dis 2014;15:451-8. [PMID: 24825443 DOI: 10.1111/1751-2980.12159] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 346 |
Smith SM, Haider RB, O'Connor H, McNamara D, O'Morain C. Practical treatment of Helicobacter pylori: a balanced view in changing times. Eur J Gastroenterol Hepatol 2014;26:819-25. [PMID: 24892516 DOI: 10.1097/MEG.0000000000000130] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 347 |
Malnick SDH, Melzer E, Attali M, Duek G, Yahav J. Helicobacter pylori: Friend or foe? World J Gastroenterol 2014; 20(27): 8979-8985 [PMID: 25083071 DOI: 10.3748/wjg.v20.i27.8979] [Cited by in F6Publishing: 19] [Reference Citation Analysis]
|
| 348 |
Mohamed SM, El Touny MA, Ahmed OA, Hafez HM. Prevalence of Helicobacter pylori among healthcare workers in endoscopy units: . Egyptian Liver Journal 2014;4:94-8. [DOI: 10.1097/01.elx.0000451423.22198.df] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 349 |
Iwamoto A, Tanahashi T, Okada R, Yoshida Y, Kikuchi K, Keida Y, Murakami Y, Yang L, Yamamoto K, Nishiumi S, Yoshida M, Azuma T. Whole-genome sequencing of clarithromycin resistant Helicobacter pylori characterizes unidentified variants of multidrug resistant efflux pump genes. Gut Pathog. 2014;6:27. [PMID: 24995043 DOI: 10.1186/1757-4749-6-27] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 350 |
Oh DH, Lee DH, Kang KK, Park YS, Shin CM, Kim N, Yoon H, Hwang JH, Jeoung SH, Kim JW, Jang ES, Jung HC. Efficacy of hybrid therapy as first-line regimen for Helicobacter pylori infection compared with sequential therapy. J Gastroenterol Hepatol 2014;29:1171-6. [PMID: 24955448 DOI: 10.1111/jgh.12518] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 351 |
Lee JY, Kim N, Kim MS, Choi YJ, Lee JW, Yoon H, Shin CM, Park YS, Lee DH, Jung HC. Factors affecting first-line triple therapy of Helicobacter pylori including CYP2C19 genotype and antibiotic resistance. Dig Dis Sci 2014;59:1235-43. [PMID: 24599773 DOI: 10.1007/s10620-014-3093-7] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 8.1] [Reference Citation Analysis]
|
| 352 |
Bang CS, Baik GH. Attempts to enhance the eradication rate of Helicobacter pylori infection. World J Gastroenterol 2014; 20(18): 5252-5262 [PMID: 24833855 DOI: 10.3748/wjg.v20.i18.5252] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 353 |
Uno K, Kato K, Shimosegawa T. Novel role of toll-like receptors in Helicobacter pylori - induced gastric malignancy. World J Gastroenterol 2014; 20(18): 5244-5251 [PMID: 24833854 DOI: 10.3748/wjg.v20.i18.5244] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 354 |
Dalal RS, Moss SF. At the bedside: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer. J Leukoc Biol 2014;96:213-24. [PMID: 24823809 DOI: 10.1189/jlb.4BT0214-100R] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 355 |
Quach DT, Hiyama T, Shimamoto F, Le QD, Ho LX, Vu NH, Yoshihara M, Uemura N. Value of a new stick-type rapid urine test for the diagnosis of Helicobacter pylori infection in the Vietnamese population. World J Gastroenterol 2014; 20(17): 5087-5091 [PMID: 24803823 DOI: 10.3748/wjg.v20.i17.5087] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 356 |
Francavilla R, Polimeno L, Demichina A, Maurogiovanni G, Principi B, Scaccianoce G, Ierardi E, Russo F, Riezzo G, Di Leo A, Cavallo L, Francavilla A, Versalovic J. Lactobacillus reuteri strain combination in Helicobacter pylori infection: a randomized, double-blind, placebo-controlled study. J Clin Gastroenterol 2014;48:407-13. [PMID: 24296423 DOI: 10.1097/MCG.0000000000000007] [Cited by in Crossref: 69] [Cited by in F6Publishing: 71] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 357 |
Gong EJ, Yun SC, Jung HY, Lim H, Choi KS, Ahn JY, Lee JH, Kim DH, Choi KD, Song HJ, Lee GH, Kim JH. Meta-analysis of first-line triple therapy for helicobacter pylori eradication in Korea: is it time to change? J Korean Med Sci 2014;29:704-13. [PMID: 24851029 DOI: 10.3346/jkms.2014.29.5.704] [Cited by in Crossref: 70] [Cited by in F6Publishing: 70] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 358 |
Hinc K, Stasiłojć M, Piątek I, Peszyńska-Sularz G, Isticato R, Ricca E, Obuchowski M, Iwanicki A. Mucosal adjuvant activity of IL-2 presenting spores of bacillus subtilis in a murine model of Helicobacter pylori vaccination. PLoS One 2014;9:e95187. [PMID: 24743850 DOI: 10.1371/journal.pone.0095187] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 359 |
Satou K, Shiroma A, Teruya K, Shimoji M, Nakano K, Juan A, Tamotsu H, Terabayashi Y, Aoyama M, Teruya M, Suzuki R, Matsuda M, Sekine A, Kinjo N, Kinjo F, Yamaoka Y, Hirano T. Complete Genome Sequences of Eight Helicobacter pylori Strains with Different Virulence Factor Genotypes and Methylation Profiles, Isolated from Patients with Diverse Gastrointestinal Diseases on Okinawa Island, Japan, Determined Using PacBio Single-Molecule Real-Time Technology. Genome Announc 2014;2:e00286-14. [PMID: 24744331 DOI: 10.1128/genomeA.00286-14] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 360 |
Zhang S, Desrosiers J, Aponte-Pieras JR, DaSilva K, Fast LD, Terry F, Martin WD, De Groot AS, Moise L, Moss SF. Human immune responses to H. pylori HLA Class II epitopes identified by immunoinformatic methods. PLoS One 2014;9:e94974. [PMID: 24740005 DOI: 10.1371/journal.pone.0094974] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 361 |
Bongers G, Pacer ME, Geraldino TH, Chen L, He Z, Hashimoto D, Furtado GC, Ochando J, Kelley KA, Clemente JC. Interplay of host microbiota, genetic perturbations, and inflammation promotes local development of intestinal neoplasms in mice. J Exp Med. 2014;211:457-472. [PMID: 24590763 DOI: 10.1084/jem.20131587] [Cited by in Crossref: 61] [Cited by in F6Publishing: 66] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 362 |
Tu H, Sun L, Dong X, Gong Y, Xu Q, Jing J, Yuan Y. Serum anti-Helicobacter pylori immunoglobulin G titer correlates with grade of histological gastritis, mucosal bacterial density, and levels of serum biomarkers. Scand J Gastroenterol 2014;49:259-66. [PMID: 24329006 DOI: 10.3109/00365521.2013.869352] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 363 |
Magen E, Delgado JS. Helicobacter pylori and skin autoimmune diseases. World J Gastroenterol 2014; 20(6): 1510-1516 [PMID: 24587626 DOI: 10.3748/wjg.v20.i6.1510] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 38] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 364 |
Garza-González E, Perez-Perez GI, Maldonado-Garza HJ, Bosques-Padilla FJ. A review of Helicobacter pylori diagnosis, treatment, and methods to detect eradication. World J Gastroenterol 2014; 20(6): 1438-1449 [PMID: 24587620 DOI: 10.3748/wjg.v20.i6.1438] [Cited by in CrossRef: 118] [Cited by in F6Publishing: 130] [Article Influence: 13.1] [Reference Citation Analysis]
|
| 365 |
Talebi Bezmin Abadi A, Mohabbati Mobarez A. High Prevalence of Helicobacter pylori hopQ II Genotype Isolated from Iranian Patients with Gastroduodenal Disorders. J Pathog. 2014;2014:842469. [PMID: 24672729 DOI: 10.1155/2014/842469] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 366 |
Ramos-Soriano AG, Black J. Nitazoxanide Use as Part of an Empiric Multi-Drug Regimen in Treating Children with Suspected Helicobacter pylori Infection. Case Rep Gastroenterol 2015;9:36-42. [PMID: 25759631 DOI: 10.1159/000375116] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 367 |
Dickson RP, Erb-Downward JR, Huffnagle GB. The role of the bacterial microbiome in lung disease. Expert Rev Respir Med. 2013;7:245-257. [PMID: 23734647 DOI: 10.1586/ers.13.24] [Cited by in Crossref: 259] [Cited by in F6Publishing: 272] [Article Influence: 28.8] [Reference Citation Analysis]
|
| 368 |
Osborn M. Antibiotics for the therapy of gastrointestinal diseases. Pocket Guide to Gastrointestinal Drugs 2014. [DOI: 10.1002/9781118481530.ch14] [Reference Citation Analysis]
|
| 369 |
Soveri LM, Osterlund P, Ruotsalainen T, Poussa T, Rautelin H, Bono P. Helicobacter pylori and gastrointestinal symptoms in diagnostics and adjuvant chemotherapy of colorectal cancer. Oncol Lett 2014;7:553-9. [PMID: 24396486 DOI: 10.3892/ol.2013.1714] [Reference Citation Analysis]
|
| 370 |
Chuang P, Walsh E, Yen T, Cho I. Applications of Next-Generation Sequencing Technologies to the Study of the Human Microbiome. Comprehensive Analytical Chemistry 2014. [DOI: 10.1016/b978-0-444-62650-9.00004-x] [Reference Citation Analysis]
|
| 371 |
Wu TC, Jones NL. Helicobacter pylori Infection and Autophagy. Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging 2014. [DOI: 10.1016/b978-0-12-405877-4.00014-7] [Reference Citation Analysis]
|
| 372 |
Seo SI, Kim HY. Helicobacter pylori-related Peptic Ulcer Disease. Korean J Med 2014;86:655. [DOI: 10.3904/kjm.2014.86.6.655] [Reference Citation Analysis]
|
| 373 |
Khetsuriani S, Khetsuriani K. Microbial Diversity in Patients with Gastroduodenal Diseases. AiM 2014;04:69-72. [DOI: 10.4236/aim.2014.42011] [Reference Citation Analysis]
|
| 374 |
Gurney S, Carvalho L, Gonzalez C, Galaviz E, Sonstein F. An Efficacious and Cost-Effective Pharmacologic Treatment for Helicobacter pylori. The Journal for Nurse Practitioners 2014;10:22-29. [DOI: 10.1016/j.nurpra.2013.09.013] [Reference Citation Analysis]
|
| 375 |
Singh R, Hussain A, Loong CK. Narrow band imaging with magnification for the diagnosis of lesions in the upper gastrointestinal tract. World J Gastrointest Endosc 2013; 5(12): 584-589 [PMID: 24368933 DOI: 10.4253/wjge.v5.i12.584] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 376 |
Lebwohl B, Blaser MJ, Ludvigsson JF, Green PH, Rundle A, Sonnenberg A, Genta RM. Decreased risk of celiac disease in patients with Helicobacter pylori colonization. Am J Epidemiol 2013;178:1721-30. [PMID: 24124196 DOI: 10.1093/aje/kwt234] [Cited by in Crossref: 93] [Cited by in F6Publishing: 103] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 377 |
Georgopoulos SD, Xirouchakis E, Martinez-Gonzalez B, Sgouras DN, Spiliadi C, Mentis AF, Laoudi F. Clinical evaluation of a ten-day regimen with esomeprazole, metronidazole, amoxicillin, and clarithromycin for the eradication of Helicobacter pylori in a high clarithromycin resistance area. Helicobacter 2013;18:459-67. [PMID: 23714140 DOI: 10.1111/hel.12062] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 378 |
Ueda J, Okuda M, Nishiyama T, Lin Y, Fukuda Y, Kikuchi S. Diagnostic accuracy of the E-plate serum antibody test kit in detecting Helicobacter pylori infection among Japanese children. J Epidemiol 2014;24:47-51. [PMID: 24240631 DOI: 10.2188/jea.je20130078] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 379 |
Salicru M, Juarez D, Genta RM. Low prevalence of H. pylori infection in patients with gastroparesis. Dig Liver Dis 2013;45:905-8. [PMID: 23768443 DOI: 10.1016/j.dld.2013.05.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 380 |
Moss SF. The rediscovery of H. pylori bacteria in the gastric mucosa by Robin Warren, and implications of this finding for human biology and disease. Dig Dis Sci 2013;58:3072-8. [PMID: 24122558 DOI: 10.1007/s10620-013-2863-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 381 |
Chen S, Ying L, Kong M, Zhang Y, Li Y. The Prevalence of Helicobacter pylori Infection Decreases with Older Age in Atrophic Gastritis. Gastroenterol Res Pract 2013;2013:494783. [PMID: 24174932 DOI: 10.1155/2013/494783] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 382 |
Kim MS, Kim N, Kim SE, Jo HJ, Shin CM, Park YS, Lee DH. Long-term follow up Helicobacter Pylori reinfection rate after second-line treatment: bismuth-containing quadruple therapy versus moxifloxacin-based triple therapy. BMC Gastroenterol. 2013;13:138. [PMID: 24050512 DOI: 10.1186/1471-230x-13-138] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 383 |
Vilaichone RK, Yamaoka Y, Shiota S, Ratanachu-ek T, Tshering L, Uchida T, Fujioka T, Mahachai V. Antibiotics resistance rate of Helicobacter pylori in Bhutan. World J Gastroenterol 2013; 19(33): 5508-5512 [PMID: 24023494 DOI: 10.3748/wjg.v19.i33.5508] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 384 |
Kim HY, Kim N, Kim SM, Seo JH, Park EH, Lee DH. Seroprevalence of Helicobacter pylori Infection in Korean Health Personnel. Gut Liver 2013;7:648-54. [PMID: 24312704 DOI: 10.5009/gnl.2013.7.6.648] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 385 |
Gatta L, Vakil N, Vaira D, Scarpignato C. Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy. BMJ 2013;347:f4587. [PMID: 23926315 DOI: 10.1136/bmj.f4587] [Cited by in Crossref: 178] [Cited by in F6Publishing: 193] [Article Influence: 17.8] [Reference Citation Analysis]
|
| 386 |
Sharaf RN, Shergill AK, Odze RD, Krinsky ML, Fukami N, Jain R, Appalaneni V, Anderson MA, Ben-Menachem T, Chandrasekhara V, Chathadi K, Decker GA, Early D, Evans JA, Fanelli RD, Fisher DA, Fisher LR, Foley KQ, Hwang JH, Jue TL, Ikenberry SO, Khan KM, Lightdale J, Malpas PM, Maple JT, Pasha S, Saltzman J, Dominitz JA, Cash BD; ASGE Standards of Practice Committee. Endoscopic mucosal tissue sampling. Gastrointest Endosc 2013;78:216-24. [PMID: 23867371 DOI: 10.1016/j.gie.2013.04.167] [Cited by in Crossref: 92] [Cited by in F6Publishing: 93] [Article Influence: 9.2] [Reference Citation Analysis]
|
| 387 |
Lim JH, Lee DH, Choi C, Lee ST, Kim N, Jeong SH, Kim JW, Hwang JH, Park YS, Lee SH, Shin CM, Jo HJ, Jang ES, Song Is, Jung HC. Clinical outcomes of two-week sequential and concomitant therapies for Helicobacter pylori eradication: a randomized pilot study. Helicobacter 2013;18:180-6. [PMID: 23305083 DOI: 10.1111/hel.12034] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 388 |
Lee JW, Kim N, Kim JM, Nam RH, Chang H, Kim JY, Shin CM, Park YS, Lee DH, Jung HC. Prevalence of primary and secondary antimicrobial resistance of Helicobacter pylori in Korea from 2003 through 2012. Helicobacter 2013;18:206-14. [PMID: 23241101 DOI: 10.1111/hel.12031] [Cited by in Crossref: 181] [Cited by in F6Publishing: 176] [Article Influence: 18.1] [Reference Citation Analysis]
|
| 389 |
Olokoba AB, Obateru OA, Bojuwoye MO. Helicobacter pylori eradication therapy: A review of current trends. Niger Med J. 2013;54:1-4. [PMID: 23661891 DOI: 10.4103/0300-1652.108884] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 390 |
Yan TL, Hu QD, Zhang Q, Li YM, Liang TB. National rates of Helicobacter pylori recurrence are significantly and inversely correlated with human development index. Aliment Pharmacol Ther 2013;37:963-8. [PMID: 23550618 DOI: 10.1111/apt.12293] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 391 |
Bhandari A, Crowe SE. Helicobacter pylori in gastric malignancies. Curr Gastroenterol Rep. 2012;14:489-496. [PMID: 23054813 DOI: 10.1007/s11894-012-0296-y] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 392 |
Sardarian H, Fakheri H, Hosseini V, Taghvaei T, Maleki I, Mokhtare M. Comparison of hybrid and sequential therapies for Helicobacter pylori eradication in Iran: a prospective randomized trial. Helicobacter 2013;18:129-34. [PMID: 23121338 DOI: 10.1111/hel.12017] [Cited by in Crossref: 74] [Cited by in F6Publishing: 77] [Article Influence: 7.4] [Reference Citation Analysis]
|
| 393 |
Wang ZK, Yang YS. Upper gastrointestinal microbiota and digestive diseases. World J Gastroenterol 2013; 19(10): 1541-1550 [PMID: 23539678 DOI: 10.3748/wjg.v19.i10.1541] [Cited by in CrossRef: 61] [Cited by in F6Publishing: 63] [Article Influence: 6.1] [Reference Citation Analysis]
|
| 394 |
Binh TT, Shiota S, Nguyen LT, Ho DD, Hoang HH, Ta L, Trinh DT, Fujioka T, Yamaoka Y. The incidence of primary antibiotic resistance of Helicobacter pylori in Vietnam. J Clin Gastroenterol 2013;47:233-8. [PMID: 23090037 DOI: 10.1097/MCG.0b013e3182676e2b] [Cited by in Crossref: 34] [Cited by in F6Publishing: 43] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 395 |
Chang SS, Hu HY. Helicobacter pylori is not the predominant etiology for liver cirrhosis patients with peptic ulcer disease. Eur J Gastroenterol Hepatol 2013;25:159-65. [PMID: 23044811 DOI: 10.1097/MEG.0b013e32835a1b26] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 396 |
Lakshmi V, Singh N, Singh P, Palit G. Role of Gastrin and Histamine in the Anti-ulcerogenic Potential of Compounds-gedunine and Photogedunine. Pharmacologia 2013;4:70-76. [DOI: 10.5567/pharmacologia.2013.70.76] [Reference Citation Analysis]
|
| 397 |
H. Ferri's Clinical Advisor 2013 2013. [DOI: 10.1016/b978-0-323-08373-7.00017-0] [Reference Citation Analysis]
|
| 398 |
von Rosenvinge EC. Microbiome, Stomach. Encyclopedia of Metagenomics 2013. [DOI: 10.1007/978-1-4614-6418-1_381-2] [Reference Citation Analysis]
|
| 399 |
Eshraghian A, Pellicano R. Comment on: Jeon et al. Helicobacter pylori infection is associated with an increased rate of diabetes. Diabetes Care 2012;35:520-525. Diabetes Care 2013;36:e20. [PMID: 23264304 DOI: 10.2337/dc12-0570] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 400 |
Wang S, Zhang W, Reineks E. Breath Tests for Detection of Helicobacter pylori and Aspergillus fumigatus. Advanced Techniques in Diagnostic Microbiology 2013. [DOI: 10.1007/978-1-4614-3970-7_2] [Reference Citation Analysis]
|
| 401 |
Al Dhahab H, McNabb-Baltar J, Al-Taweel T, Barkun A. State-of-the-art management of acute bleeding peptic ulcer disease. Saudi J Gastroenterol 2013;19:195-204. [PMID: 24045592 DOI: 10.4103/1319-3767.118116] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 402 |
Porras C, Nodora J, Sexton R, Ferreccio C, Jimenez S, Dominguez RL, Cook P, Anderson G, Morgan DR, Baker LH, Greenberg ER, Herrero R. Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG Trial S0701). Cancer Causes Control 2013;24:209-15. [PMID: 23263777 DOI: 10.1007/s10552-012-0117-5] [Cited by in Crossref: 75] [Cited by in F6Publishing: 70] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 403 |
Liang J, Li J, Han Y, Xia J, Yang Y, Li W, Zhang S, Wu Y, Yuan Y, Li Z, Du Y, Chen M, Chen B, Jiang B, Bai Y, Wen Q, Wu K, Fan D. Helicobacter pylori eradication with ecabet sodium, omeprazole, amoxicillin, and clarithromycin versus bismuth, omeprazole, amoxicillin, and clarithromycin quadruple therapy: a randomized, open-label, phase IV trial. Helicobacter 2012;17:458-65. [PMID: 23066868 DOI: 10.1111/j.1523-5378.2012.00971.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 404 |
Gisbert JP, Calvet X, Ferrándiz J, Mascort J, Alonso-Coello P, Marzo M; Sociedad Española de Medicina de Familia y Comunitaria. [Clinical practice guideline on the management of patients with dyspepsia. Update 2012]. Gastroenterol Hepatol 2012;35:725.e1-38. [PMID: 23186826 DOI: 10.1016/j.gastrohep.2012.05.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 405 |
Al Dhahab H, Barkun A. The Acute Management of Nonvariceal Upper Gastrointestinal Bleeding. Ulcers 2012;2012:1-8. [DOI: 10.1155/2012/361425] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 406 |
Gisbert JP, Calvet Calvo X, Ferrándiz Santos J, Mascort Roca JJ, Alonso-Coello P, Marzo Castillejo M; Asociación Española de Gastroenterología., Sociedad Española de Medicina de Familia y Comunitaria., Centro Cochrane Iberoamericano. [Managing of the patient with dyspepsia. Clinical Practice Guideline. Update 2012]. Aten Primaria 2012;44:728-33. [PMID: 23089244 DOI: 10.1016/j.aprim.2012.07.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 407 |
Gisbert JP, Calvet X, Ferrándiz J, Mascort J, Alonso-Coello P, Marzo M; Asociación Española de Gastroenterología., Sociedad Española de Medicina de Familia y Comunitaria., Centro Cochrane Iberoamericano. [Clinical practice guideline on the management of patients with dyspepsia. Update 2012]. Aten Primaria 2012;44:727.e1-727.e38. [PMID: 23036729 DOI: 10.1016/j.aprim.2012.05.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 408 |
Gasparetto M, Pescarin M, Guariso G. Helicobacter pylori Eradication Therapy: Current Availabilities. ISRN Gastroenterol. 2012;2012:186734. [PMID: 22900197 DOI: 10.5402/2012/186734] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 409 |
References. Medical Microbiology Testing in Primary Care 2012. [DOI: 10.1201/b15133-15] [Reference Citation Analysis]
|
| 410 |
Baudon J, Lemale J. Úlceras gastroduodenales del niño. EMC - Pediatría 2012;47:1-10. [DOI: 10.1016/s1245-1789(12)61922-2] [Reference Citation Analysis]
|
| 411 |
Jones N, Chiba N, Fallone C, Thompson A, Hunt R, Jacobson K, Goodman K; Canadian Helicobacter Study Group Participants. Helicobacter pylori in First Nations and recent immigrant populations in Canada. Can J Gastroenterol 2012;26:97-103. [PMID: 22312609 DOI: 10.1155/2012/174529] [Cited by in Crossref: 22] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 412 |
Nkuize M, De Wit S, Muls V, Ntounda R, Gomez-Galdon M, Buset M. Comparison of demographic characteristics and upper gastrointestinal endoscopy findings in HIV-positive, antiretroviral-treated patients with and without Helicobacter pylori coinfection. Helicobacter 2012;17:153-9. [PMID: 22404447 DOI: 10.1111/j.1523-5378.2011.00929.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 413 |
Gisbert JP, Castro-Fernandez M, Perez-Aisa A, Cosme A, Molina-Infante J, Rodrigo L, Modolell I, Cabriada JL, Gisbert JL, Lamas E, Marcos E, Calvet X. Fourth-line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failures. Aliment Pharmacol Ther 2012;35:941-7. [PMID: 22372560 DOI: 10.1111/j.1365-2036.2012.05053.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 414 |
Gisbert JP, Calvet X. Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori. Clin Exp Gastroenterol. 2012;5:23-34. [PMID: 22457599 DOI: 10.2147/ceg.s25419] [Cited by in Crossref: 97] [Cited by in F6Publishing: 107] [Article Influence: 8.8] [Reference Citation Analysis]
|
| 415 |
Cho I, Blaser MJ. The human microbiome: at the interface of health and disease. Nat Rev Genet 2012;13:260-70. [PMID: 22411464 DOI: 10.1038/nrg3182] [Cited by in Crossref: 2127] [Cited by in F6Publishing: 2205] [Article Influence: 193.4] [Reference Citation Analysis]
|
| 416 |
Cho I, Blaser MJ. The human microbiome: at the interface of health and disease. Nat Rev Genet. 2012;13:260-270. [PMID: 22411464 DOI: 10.1038//nrg3182] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 417 |
Tielemans MM, van Oijen MG, Mulder CJ, Vos KJ, Lems WF. Esomeprazole relieves upper gastrointestinal symptoms in high-risk and average-risk NSAID users in daily clinical practice: results from an open-label study. Eur J Gastroenterol Hepatol 2012;24:281-7. [PMID: 22246328 DOI: 10.1097/MEG.0b013e32834f4d19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 418 |
Oh HS, Lee DH, Seo JY, Cho YR, Kim N, Jeoung SH, Kim JW, Hwang JH, Park YS, Lee SH, Shin CM, Cho HJ, Jung HC, Song IS. Ten-day sequential therapy is more effective than proton pump inhibitor-based therapy in Korea: a prospective, randomized study. J Gastroenterol Hepatol 2012;27:504-9. [PMID: 21916989 DOI: 10.1111/j.1440-1746.2011.06922.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 419 |
Gargallo C, Aranguren García P, Gomollón F. Infección por Helicobacter pylori. Medicine - Programa de Formación Médica Continuada Acreditado 2012;11:90-96. [DOI: 10.1016/s0304-5412(12)70266-4] [Reference Citation Analysis]
|
| 420 |
Grad YH, Lipsitch M, Aiello AE. Secular trends in Helicobacter pylori seroprevalence in adults in the United States: evidence for sustained race/ethnic disparities. Am J Epidemiol 2012;175:54-9. [PMID: 22085628 DOI: 10.1093/aje/kwr288] [Cited by in Crossref: 101] [Cited by in F6Publishing: 105] [Article Influence: 9.2] [Reference Citation Analysis]
|
| 421 |
Bradley JS, Sauberan JB. Antimicrobial Agents. Principles and Practice of Pediatric Infectious Diseases 2012. [DOI: 10.1016/b978-1-4377-2702-9.00294-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 422 |
Farrington M, Sharma SK. Chemotherapy of bacterial infections. Clinical Pharmacology 2012. [DOI: 10.1016/b978-0-7020-4084-9.00053-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 423 |
Offermanns S. Die Magenfunktion beeinflussende Pharmaka. Pharmakologie & Toxikologie 2012. [DOI: 10.1007/978-3-642-12354-2_45] [Reference Citation Analysis]
|
| 424 |
Singh Bansi D, Louis-auguste J. Oesophagus, stomach and duodenum. Clinical Pharmacology 2012. [DOI: 10.1016/b978-0-7020-4084-9.00071-9] [Reference Citation Analysis]
|
| 425 |
Gisbert JP, Calvet X. Review article: rifabutin in the treatment of refractory Helicobacter pylori infection. Aliment Pharmacol Ther 2012;35:209-21. [PMID: 22129228 DOI: 10.1111/j.1365-2036.2011.04937.x] [Cited by in Crossref: 137] [Cited by in F6Publishing: 129] [Article Influence: 12.5] [Reference Citation Analysis]
|
| 426 |
Kuipers EJ, Blaser MJ. Acid Peptic Disease. Goldman's Cecil Medicine 2012. [DOI: 10.1016/b978-1-4377-1604-7.00141-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 427 |
Baudon J, Lemale J. Ulcères gastroduodénaux de l'enfant. EMC - Pédiatrie - Maladies infectieuses 2012;7:1-10. [DOI: 10.1016/s1637-5017(12)70023-6] [Reference Citation Analysis]
|
| 428 |
Gisbert JP, Calvet X. Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough. Aliment Pharmacol Ther 2011;34:1255-68. [PMID: 22017749 DOI: 10.1111/j.1365-2036.2011.04887.x] [Cited by in Crossref: 93] [Cited by in F6Publishing: 92] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 429 |
Zhang S, Moise L, Moss SF. H. pylori vaccines: why we still don’t have any. Hum Vaccin. 2011;7:1153-1157. [PMID: 22048119 DOI: 10.4161/hv.7.11.17655] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 430 |
Gisbert JP, Calvet X. Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori. Aliment Pharmacol Ther 2011;34:604-17. [PMID: 21745241 DOI: 10.1111/j.1365-2036.2011.04770.x] [Cited by in Crossref: 126] [Cited by in F6Publishing: 121] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 431 |
Lee JW, Kim N, Nam RH, Park JH, Kim JM, Jung HC, Song IS. Mutations of Helicobacter pylori associated with fluoroquinolone resistance in Korea. Helicobacter 2011;16:301-10. [PMID: 21762270 DOI: 10.1111/j.1523-5378.2011.00840.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 432 |
Dore MP, Farina V, Cuccu M, Mameli L, Massarelli G, Graham DY. Twice-a-day bismuth-containing quadruple therapy for Helicobacter pylori eradication: a randomized trial of 10 and 14 days. Helicobacter 2011;16:295-300. [PMID: 21762269 DOI: 10.1111/j.1523-5378.2011.00857.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 433 |
Hasni S, Ippolito A, Illei GG. Helicobacter pylori and autoimmune diseases. Oral Dis. 2011;17:621-627. [PMID: 21902767 DOI: 10.1111/j.1601-0825.2011.01796.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 45] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 434 |
. Infection à Helicobacter pylori et résistance à la trithérapie. Revue Francophone des Laboratoires 2011;2011:28. [DOI: 10.1016/s1773-035x(11)70761-4] [Reference Citation Analysis]
|
| 435 |
Moss SF, Moise L, Lee DS, Kim W, Zhang S, Lee J, Rogers AB, Martin W, De Groot AS. HelicoVax: epitope-based therapeutic Helicobacter pylori vaccination in a mouse model. Vaccine. 2011;29:2085-2091. [PMID: 21236233 DOI: 10.1016/j.vaccine.2010.12.130] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 436 |
Chouraqui J. Gastro-entérologie. Pédiatrie 2011. [DOI: 10.1016/b978-2-294-71375-0.50014-3] [Reference Citation Analysis]
|
| 437 |
Talebi Bezmin Abadi A, Mobarez AM, Taghvaei T, Wolfram L. Antibiotic resistance of Helicobacter pylori in Mazandaran, North of Iran. Helicobacter 2010;15:505-9. [PMID: 21073606 DOI: 10.1111/j.1523-5378.2010.00795.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 438 |
Grau AJ, Urbanek C, Palm F. Common infections and the risk of stroke. Nat Rev Neurol 2010;6:681-94. [PMID: 21060340 DOI: 10.1038/nrneurol.2010.163] [Cited by in Crossref: 126] [Cited by in F6Publishing: 138] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 439 |
Manolakis AC, Kapsoritakis AN, Tiaka EK, Satra M, Gerovassili A, Tsiompanidis I, Vamvakopoulos N, Potamianos SP. Impact of TLR-4 polymorphisms on circulating levels of antibodies against Helicobacter pylori. Helicobacter 2010;15:481-2. [PMID: 21083756 DOI: 10.1111/j.1523-5378.2010.00785.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 440 |
Griffiths H. Module 5. Pharmacological Management of Dyspepsia. Nurse Prescribing 2010;8:1-10. [DOI: 10.12968/npre.2010.8.9.cpd1] [Reference Citation Analysis]
|
| 441 |
Marais O. Le point sur l’infection à Helicobacter pylori. Option/Bio 2010;21:6. [DOI: 10.1016/s0992-5945(10)70468-2] [Reference Citation Analysis]
|
| 442 |
Zamani M, Vahedi A, Tamaddoni A, Bijani A, Bagherzade M, Shokri-Shirvani J. Relationship between β-Thalassemia minor and Helicobacter pylori infection. Caspian J Intern Med 2018;9:54-9. [PMID: 29387320 DOI: 10.22088/cjim.9.1.54] [Reference Citation Analysis]
|
